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ABSTRACT OF THE DISSERTATION
VEGF and Sympathetic Perivascular Nerves Contribute to Hypoxic
Remodeling of Ovine Cranial Arteries
By
Olayemi Olufikayo Adeoye
Doctor of Philosophy, Graduate Program in Physiology
Loma Linda University, June 2013
Dr. William J. Pearce, Chairperson
Chronic hypoxia complicates many pregnancies and can result in postnatal
pathologies that include compromised fetal cardiovascular structure and function.
Mechanisms involved remain unclear. Because hypoxia increases production of VEGF,
known to modulate smooth muscle (SM) phenotype, this thesis explored the hypothesis
that VEGF contributes to hypoxic fetal vascular remodeling through direct effects on SM
cells and indirectly through perivascular nerves. Using a chronic hypoxia sheep model,
this work demonstrated that: 1) hypoxia potently upregulates VEGF receptor expression
but not endogenous VEGF level in fetal ovine carotid arteries; 2) both chronic hypoxia
and VEGF exert similar effects on smooth muscle contractile proteins; 3) both chronic
hypoxia and VEGF exert similar effects on contractile protein colocalizations; and lastly,
sympathetic autonomic nerves contribute to hypoxic reorganization of structure and
function of vascular contractile proteins. Together, these findings advance understanding
of how hypoxia precipitates fetal vascular remodeling and offer an essential first step
toward finding new treatments for infants that survive in-utero hypoxia.
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CHAPTER ONE
INTRODUCTION
Hypoxia
Situations ranging from physiological increases in physical activity leading to
transient decreases in vascular oxygen concentration to partial or complete obliteration of
oxygen supply to body tissues result in hypoxia. In many cases, organisms are able to
mount adaptive mechanisms to compensate for these decreases in oxygen tension,
however in other cases, they succumb to the deleterious effects of prolonged periods of
hypoxia. In more general terms, hypoxia results from conditions that create a mismatch
between cellular oxygen demand and hematological supply of oxygen. Everyone gets
exposed to varying levels of hypoxia such as ascending to high altitude, deep sea diving,
inhalation of mixture of gases with very low oxygen content such as kitchen smoke,
cigarette smoke, smog from vehicles etc. Factors that determine outcome of exposure to
hypoxia include but not limited to: levels of exposure, duration of exposure, age, and
time to intervention. Individual genetic makeup also has a role to play in prognosis of
hypoxia induced pathologies. Under many circumstances, pulse oximetry readings of
between 95 and 100 are taken as sufficient indicator of adequate tissue oxygenation;
levels below 90 are generally low. Whereas a lot of studies have focused on responses of
adults to hypoxic conditions, not much is known about fetal responses to hypoxia.
Normal pregnancy involves a chronic state of mild glucose intolerance as well as
blood volume expansion associated with considerable cardiovascular and metabolic
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adaptations which when compromised result in maldevelopment of fetus (31). Whereas
hypoxia is commonly referred to as a pathological phenomenon, the developing
mammalian embryo which develops in a low-oxygen tension environment benefits from
regulators of hypoxia which target specific genes to promote anaerobic metabolism hence
reducing oxygen consumption. At the same time, other regulators of hypoxia alleviate
adverse effects of hypoxia by expanding the surrounding vasculature (21).
Chronic prenatal fetal hypoxia occurs during many obstetric pathologies,
including those associated with impaired placental perfusion (51) , pregnancy associated
hypertension / eclampsia /preeclampsia (31, 49) and maternal diabetes (61). A 2006
study, which identified maternal influences on stillbirths and neonatal deaths in Australia,
showed that, intrauterine hypoxia and asphyxia were the most common etiologies of
stillbirth and were initiated during the perinatal period. Factors such as prematurity, low
birth weight, smoking during pregnancy and poor prenatal care complicate further the
deleterious effects of hypoxia on the developing fetus (49). Both of these modifiable and
intrinsic/genetic factors culminate in conditions that result in angiopathies, which alter
utero-placental perfusion and consequently intrauterine fetal hypoxia.
Although sustained or prolonged severe hypoxia is lethal to the fetus, multiple
homeostatic or compensatory mechanisms enable the fetus to survive more moderate sublethal hypoxia. Such mechanisms typically involve increases in fetal erythropoietin levels
and hematocrit. In many clinical scenarios, erythropoietin levels in fetal plasma and
amniotic fluid have been used as an indicator of chronic intrauterine hypoxia, since it
does not cross the placenta and is not stored (72). Chronic hypoxia also orchestrates a
redistribution of cardiac output by the fetal cardiovascular system to favor the developing
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brain and heart, which have very low tolerance to low oxygen tension (70). In addition to
upregulation of hypoxia inducible molecular regulators, chronic fetal hypoxia also
stimulates a broad variety of structural and functional changes in the developing
cardiovascular system through a process collectively known as hypoxic vascular
remodeling (70).

Hypoxic Vascular Remodeling
Since the coining of the term hypoxic vascular remodeling (63), several studies
have attempted to characterize mechanisms as well as changes initiated and maintained
by decreased oxygen tension. Hypoxia has been shown extensively to bring about
changes in structure, biochemical composition as well as functional changes in the
diverse cell types that make up the fetal vasculature (70). These changes are effected
differently in different age groups, species, sites of hypoxic exposures, duration of
exposure, developmental stage of exposure amongst others (70). The whole concept of
hypoxic site and time specific alterations could then be reasonably suggested to be
responsible for the diverse cellular and molecular alterations in different cells, tissues and
organs in the body (75). A vast majority of studies done to elucidate processes involved
with hypoxic vascular remodeling have shown that this process is particularly prominent
in the pulmonary circulation where dramatic increases in arterial wall thicknesses and
decreased contractility occur (33, 48). These structural and functional changes occur
differently in large and small arteries (70), between different artery types (74), between
cells of different phenotypes (75) and between mature and immature arteries (48).
Hypoxic vascular remodeling is a common and continuous process in many
vascular beds that matches vascular structure and function to metabolic demand in both
3

the pulmonary and systemic circulations (20, 55). It is particularly important during
periods of rapid growth such as those typical of intrauterine growth during pregnancy and
postnatal maturation (14, 47). It is also characteristic of other pathological processes
including changes due to ischemia (50) and cancer (11, 59). Because the vasculature is
made up of a heterogeneous mix of cells, responses to chronic hypoxia are distinctly
regulated in each of these cell types (15). Cellular responses to hypoxia involve gradients
of a myriad of growth factors released from both the endothelium and the adventitial
stromal cells (10, 70) as well as recruitment of various cell types e.g. bone marrow
derived cells (35). Chronic exposure of fetuses to hypoxia result in deficits in
transitioning from in-utero life to newborn and adult life (58). Hypoxia induced structural
changes result in functional reactivity to various trophic factors. Among the many
functional consequences is a marked decrease in vascular tone (2, 56). Just as the hypoxia
orchestrated vascular changes are diverse, the molecular mechanisms that mediate them
are equally diverse. Numerous influences including the mitogenic effects of endothelium
expressed molecules such as endothelin (43), nitric oxide and soluble guanylate cyclase
(66) as well as serotonin and rho-kinase (23)amongst others have been suggested as
potential mediators of hypoxic vascular remodeling.
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Hypoxia Inducible Factor (HIF) and Vascular Endothelial Growth
Factor (VEGF)
Hypoxia Inducible Factor-1 (HIF-1) has been suggested as the global mediator of
hypoxia (76). HIF-1 is a basic helix-loop-helix-PAS domain transcription factor
composed of an alpha and beta subunits. Whereas under normoxic conditions, HIF-1α is
synthesized but rapidly ubiquitinated and targeted for degradation by the 26S proteosome
(67), under hypoxic conditions, it stabilizes, accumulates and dimerizes with the β
subunit, recruits coactivators such as Creb Binding Protein (CBP) and Protein 300 (p300)
subsequently activating transcription of hundreds of genes encoding angiogenic cytokines
in a cell type-specific manner (68). Hypoxic increases in HIF-1 results in transcriptional
upregulation of glycolytic enzymes, erythropoietin (EPO), Placental Growth Factor
(PLGF) and Vascular Endothelial Growth Factor (VEGF) amongst others.
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Figure 1. Molecular mechanisms of oxygen homeostasis. Left, under normoxic
conditions, HIF-1α is synthesized, but is rapidly subjected to prolyl hydroxylation by the
PHD2-OS9 complex and asparaginyl hydroxylation by FIH-1 (not shown). Prolyl
hydroxylated HIF-1a is bound by VHL, which together with SSAT2 recruits Elongin C,
which in turn recruits a ubiquitin ligase complex containing Elongin B (B), ring box
protein 1 (RBX1), cullin 2 (CUL2), and an E2 ubiquitin conjugating enzyme.
Ubiquitination of HIF-1α targets the protein for degradation by the 26S proteasome.
Right, under hypoxic conditions, HIF-1α accumulates, dimerizes with HIF-1β, recruits
the coactivators CBP/p300, and activates the transcription of genes encoding angiogenic
cytokines including PLGF, VEGF, and SDF-1. The protein products of these genes are
secreted and bind to their cognate receptors (VEGFR1, VEGFR1/VEGFR2, and CXCR4,
respectively), which are located on the plasma membrane of vascular endothelial cells
and circulating angiogenic cells. The diagram is simplified: cells may express one, two,
or three of the receptors shown, as well as receptors for other cytokines, which are not
shown. (68)
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Vascular Endothelial Growth Factor
The path to discovering this very important molecule started in the late 1800s
when some German pathologists observed that tumors were highly vascularized (24).
This was a very fascinating finding that stirred up scientists’ curiosity about possible
mediators of tumor vascularity, prompting various researches to discovery potent
inhibitors of such mediators of extensive vascular supply of tumors. One of the pioneers
of this field was Judah Folkman who made the first attempt to isolate a specific
proangiogenic signal he named “tumor angiogenic factor-TAF” in 1971 (28) and
suggested that application of potent inhibitors of this isolated molecule had the potential
to arrest growth and differentiation of solid tumors at very early stages. In addition to the
well-established establishment of extensive vascular network in tumors, Senger and
Dvorak in11983 showed that a partially purified protein later named “Vascular
Permeability Factor” was able to induce leakages in blood vessels (69). In 1989, Ferrara
in Genentech, isolated and cloned an endothelial cell mitogen named Vascular
Endothelial Growth Factor and was later confirmed to be same as the earlier discovered
Vascular Permeability Factor (26).
VEGF, also known as Vasculotropin is a 34 to 42 KDa homodimeric, heparinbinding glycoprotein. It is one of the most important growth factors with proangiogenic
properties as well as serving to potentiate microvascular hyperpermeability, which
precedes or occurs simultaneously as angiogenesis. The VEGF family is made up of
seven members: VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, VEGF-F and PlGF.
Each one of these VEGF members has a common core VEGF homology domain
composed of a cysteine knot motif with eight invariant cysteine residues involved in
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inter- and intramolecular disulfide bonds at one end of a conserved central four-stranded
beta sheet within each monomer, which dimerize in an antiparallel, side by side
orientation (36, 52).

8

Figure 2. Ribbon representation of the receptor-binding domain of VEGF showing a
monomer in a and a dimer in b. The two-disulfide bonds are shown as black lines. Helix
a1 consists of residues 16 to 24, and the central four-stranded b-sheet is formed by b1
(residues 27–34), b3 (51–58), b5 (73–83), and b6 (89–99), with the characteristic cysteine
knot motif at one end [strands b4 (67–69) and b7 (103–105)], and a short three-stranded
b-sheet [strands b2 (46–49), b5, and b6] at the other end. VEGF monomers dimerize in an
antiparallel way.
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Members of the VEGF family are grouped based on the length of their tails and
their ability to bind to the extracellular matrix. VEGF-A is the most important and
abundant of all 7 VEGF types. In normal tissues, the highest amounts of VEGF-A are
found in adult lung, kidney, heart and adrenal gland. There are at least seven
homodimeric isoforms of VEGF-A containing: 121, 145, 148, 165, 183, 189 or 206
amino acids. The primary VEGF-A transcript derives from a single VEGF-A gene is
derived from a single VEGF-A gene, coding for eight exons. Amino acids encoded by
exons 1 to 5 and 8 are conserved in all isoforms except VEGF-148. Variable alternative
splicing occurs in exons 6 and 7, which encode two distinct heparin-binding domains.
These domains are important determinants of solubility and receptor binding
propensities. VEGF A-121 which lacks heparin binding domains encoded by both exons
6 and 7 is highly diffusible, VEGF A-165 which has only one heparin-binding region
encoded by exon 7 is moderately diffusible and VEGF A-145, 189 and 206 which contain
heparin-binding domains encoded by exon 6 are tightly bound to cell surface heparincontaining proteoglycans in the extracellular matrix (54). Hypoxia results in both
upregulation and stabilization of VEGF mRNA. Several studies have shown that an
RNA-binding protein known as HuR mediates stabilization of VEGF mRNA. HuR does
this through either direct inhibition of specific endonucleases involved with VEGF
mRNA degradation or alteration of structure of the adenylate-rich elements (AREs), thus
rendering those sites inaccessible to putative endonucleases (42).
VEGF has been shown to be a key regulator of physiologic – embryogenesis,
reproductive functions and skeletal growth as well as pathological angiogenesis – tumors,
diabetes and intraocular neovascular diseases (25). Some of the valuable physiologic
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roles of VEGF shown both in-vitro and in-vivo include stimulation of surfactant
production by alveolar type II cells (16), prevention of apoptosis induced by serum
starvation (30), promotion of monocyte chemotaxis (13) resulting in colony formation by
mature subsets of progenitor cells in the bone marrow. Its ability to induce vascular
leakages (69) (22) has been implicated in inflammatory and other pathological processes.
Biological effects of VEGF are mediated by three tyrosine kinase VEGF receptors: The
fms-like tyrosine kinase Flt-1 (VEGFR-1/Flt-1), the kinase domain region, also known as
fetal liver kinase (VEGFR-2/KDR/Flk-1) and Flt-4 (VEGFR-3) (36). Most previous work
suggests that VEGF acts mainly on the vascular endothelium (44) (27); some actually say
it’s a specific mitogen for the endothelium (36) (46). In recent times however, there has
been a growing evidence that VEGF has potent trophic effects on non-endothelial cells
including smooth muscle cells (8) (12) (57) (34) (4), placenta (37) (3) (62) and neurons
(7) (53). VEGF primarily acts through VEGF tyrosine receptor kinases resident on these
cell types. VEGF has also been shown to exert potent chemoattractant effect on various
cell types, trafficking them into blood vessel walls, these cells include pericytes (5),
progenitor cells (19, 35) (18) etc.
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Figure 3. Pathway showing VEGF signaling through its VEGF receptor 2 (Flk-1 in sheep
and KDR in humans). VEGF mediates processes of cell survival through Src / PI3K /
AKT pathway, migration through p38 / MAPK pathway and proliferation through PLCγ /
PKC pathway.
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Neurogenic Regulation of Cerebral Blood Flow
VEGF and The Neuron
Of much clinical relevance is the discovery that VEGF can promote the growth and
differentiation of the sympathetic perivascular innervation (45). This exciting finding
spurred research that has shown neuroprotective potential for VEGF and hence its
promising therapeutic advantages (65). This non-angiogenic activity of VEGF on neurons
stems from the finding that VEGF receptors are resident on neurons and astrocytes in the
central nervous system (64). Together, these studies provide evidence for a potential role
of VEGF in hypoxic vascular remodeling, because the sympathetic perivascular
innervation has been shown to exert a robust trophic influence on vascular smooth
muscle (6) (9) (17). One of the main neurotransmitter vasotrophic factor released from
sympathetic nerves is Norepinephrine (71), which exerts its trophic influence through
activation of alpha-adrenergic-1A receptors and subsequent activation of ERK (77).
Other potent nerve released factors include neuropeptide-Y, which has been shown to
colocalize with Norepinephrine in synaptic vesicles (73). NPY stimulates smooth muscle
contraction through activation of Y1 receptors, which also mediate activation of
calmodulin dependent kinase and ERK thereby influencing transcription (73) (60).
Sympathetic nerves can also release ATP which together with its breakdown product
adenosine, can exert additional trophic effects on smooth muscle (14) (9) (73) (1).

VEGF, Transmural Gradients and Phenotype Transformation
Blood vessels are composed of a highly heterogeneous group of cells that are able
to adopt various phenotypes depending on the prevailing intrinsic and extrinsic stimuli
(29) (32) (38). A huge variety of vasotrophic factors have been suggested to exert effects
13

resulting in phenotypic changes in these cells. Vascular endothelium, which is closest in
proximity to the circulating blood and affected by factors such as perfusion and shear
stress as well as non-vascular parenchyma have both been suggested as potential sources
of various vasotrophic factors (40) (41). Some studies have suggested that vasotrophic
factor gradients are set up between vascular endothelium and parenchyma (29) (32). One
of such factors with great propensity to set up gradients in the vascular bed is VEGF.
With a potent ability to mediate vascular permeability, promote endothelial cell
transformation and promote angiogenesis, VEGF remains a logical candidate to be
considered in vascular remodeling. Our research group tested the hypothesis that smooth
muscle cells are organized into lamina of similar phenotype with characteristics that
depend on the relative position between the lumen and the adventitia and involve the
direct effects of VEGF on arterial smooth muscle independent of the vascular
endothelium (10). We showed that VEGF directly alters arterial structure and
contractility through endothelium-independent effects on cells that occupy the vascular
intima (10). Various experimental data also showed that despite the fact that both VEGF
receptors 1 (flt-1) and 2 (flk-1) were present in both fetal and adult arteries, VEGF effects
mediated contractile effects only in the adult arteries. Previous data also show that the
expression and colocalization between contractile proteins vary with vasotrophic
gradients across the artery wall. VEGF has also been shown to alter phenotype of medial
wall cells as evidenced by a transition in expression and colocalization between heavy
chain myosin isoforms and their contractile thin actin filaments. In our previous studies,
whereas non-muscle myosin heavy chain isoform (NM-MHC) increased with hypoxia in
both fetal and adult arteries, total smooth muscle myosin heavy chain (SM-MHC)
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decreased only in the fetal with a significant increase in adult arteries (39). Low dose
VEGF in culture produced similar patterns of change as hypoxia on NM-MHC
abundance in fetal but not adult arteries. VEGF had no effect on SM-MHC abundance in
both fetal and adult arteries. Changes in NM-MHC correlate with contractile changes
observed in both age groups. Since SM-MHC abundance increases in adult arteries could
not explain decreased myogenic tone observed, colocalization studies were done.
Colocalization data shows that chronic hypoxia and VEGF decrease colocalization of
SM-MHC with smooth muscle alpha actin, which explains why contractile tone reduces
with hypoxia (39).
Together these initial work suggests that long-term hypoxia significantly alters
tone, contractile protein abundance and colocalization and that VEGF contributes to this
process through alteration of contractile protein abundance and colocalization as well as
setting up of gradients to which different groups of cells react differently (10). This
dissertation explored the hypothesis that VEGF and sympathetic perivascular nerves
contribute to hypoxic remodeling of ovine cranial arteries.
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Abstract
Recent studies suggest that vascular endothelial growth factor (VEGF) can
modulate smooth muscle phenotype and consequently the composition and function of
arteries upstream from the microcirculation where angiogenesis occurs. Given that
hypoxia potently induces VEGF, the present study explores the hypothesis that in fetal
arteries VEGF contributes to hypoxic vascular remodeling through changes in the
abundance, organization and function of contractile proteins. Pregnant ewes were
acclimatized at sea level or at altitude (3820 m) for the final 110 days of gestation.
Carotid arteries collected from the fetuses at term were denuded of endothelium and used
fresh or after organ culture for 24 h in a physiological concentration (3 ng/ml) of VEGF.
After 110 days, hypoxia had no effect on VEGF abundance, but markedly increased
abundances of both the Flk-1 (171%) and Flt-1 (786%) VEGF receptors. Hypoxia had no
effect on smooth muscle a-actin (SMαA), decreased myosin light chain kinase (MLCK),
and increased 20 kDa regulatory myosin light chain (MLC20) abundances. Hypoxia also
increased colocalization of MLCK with SMαA, MLC20 with SMαA, and MLCK with
MLC20. Compared to hypoxia, organ culture with VEGF produced the very same pattern
of changes in contractile protein abundances and colocalization. Effects of VEGF on
colocalization were blocked by the VEGF receptor antagonists vatalanib (240 nM) and
dasatinib (6.3 nM). Thus, through increases in VEGF receptor density, hypoxia can
recruit VEGF to help mediate remodeling of fetal arteries upstream from the
microcirculation. The results support the hypothesis that VEGF contributes to hypoxic
vascular remodeling through changes in the abundance, organization and function of
contractile proteins.
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Introduction
In-utero hypoxia secondary to maternal diabetes (49), smoking (3), pulmonary
insufficiency or placental malformation (36) is a frequent etiologic factor in many
complicated pregnancies (25). These hypoxic insults result in numerous perinatal and
postnatal morbidities (30) that often include altered fetal cardiovascular function
secondary to atypical patterns of vascular structure and contractility collectively known
as remodeling (16, 32). Whereas the exact molecular mechanisms governing hypoxic
fetal vascular remodeling remain poorly understood, considerable evidence in adult
vasculature demonstrates that chronic hypoxia orchestrates arterial wall thickening (17,
39) together with changes in contractile protein abundance (48) and organization (55).
The functional consequences of these changes include altered arterial contractility (8, 51)
due at least in part to modified reactivity of both thick and thin filament contractile
proteins (35).
Efforts to understand the mechanisms that drive hypoxic vascular remodeling have
focused largely on the vasotrophic factors released by hypoxia, the most prominent of
which is hypoxia inducible factor (HIF) (46, 56). Upregulation, stabilization and
dimerization of HIF mediate transcription of multiple angiogenic genes including VEGF
(Figure 1), which in turn is known traditionally to mediate capillary angiogenesis (18). In
further support of angiogenesis, some studies have also suggested that hypoxia can
modulate levels of the VEGF receptors 1 and 2 (Flt-1 and Flk-1) in the vascular
endothelium as well as in certain tumors of rodent brain (43, 50) (Figure 1). Whereas
abundant previous work suggests that VEGF acts mainly on the vascular endothelium
(18), recent findings further suggest that VEGF can exert potent trophic effects on
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multiple non-endothelial cell types (24) suggesting possible expression of VEGF
receptors on such cell types. Of particular relevance to vascular remodeling is growing
evidence that VEGF has potent trophic effects on smooth muscle cells (12) that result in
alteration of contractile protein expression and organization (7).
The current study explores the hypothesis that VEGF contributes to hypoxic fetal
vascular remodeling through changes in the abundance, organization and function of
contractile proteins. Through increases in VEGF and/or its receptors in smooth muscle,
we propose that hypoxia could recruit VEGF to help mediate changes in ovine fetal
vascular structure and function that are characteristic of chronic hypoxia. Given the
central importance of the rate-limiting enzyme myosin light chain kinase (MLCK) (41),
its substrate, regulatory myosin light chain (MLC20) (20), and their contractile partner
smooth muscle α-Actin (SMαA) (15), our experimental design focused on mechanisms
involved in hypoxia-induced changes in these contractile proteins. Comparisons between
fetal arteries harvested from sheep maintained at sea level and those maintained at high
altitude (3820m) for 110 days served to define effects of chronic hypoxia, as previously
described in detail (32). To assess the role of VEGF and its receptors in hypoxic
remodeling (Figure 1), we used organ cultures of whole carotid arteries, which preserved
the spatial organization of all cell types in the arterial wall (24). To explain changes in
smooth muscle phenotype orchestrated by hypoxia, which ultimately dictate contractile
protein abundance and organization, we assessed contractile protein abundances via
Western blots and protein organization via a novel confocal colocalization imaging
technique (9). Stress-strain measurements of myogenic reactivity normalized to arterial
wall cross-sectional area (34) identified the functional consequences of arterial
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remodeling induced by hypoxia. Together, these studies provided a unique perspective of
the direct contribution of VEGF and its receptors to hypoxic vascular remodeling in fetal
ovine carotid arteries.
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Figure 1: This schematic summarizes our approach to test the hypothesis that VEGF
contributes to hypoxic vascular remodeling through changes in the abundance,
organization and function of contractile proteins in fetal arteries. First, we propose that
hypoxia induces short-term increases in VEGF (Arrow 1) through upregulation of the
transcription factor hypoxia inducible factor. We further propose that these increases in
VEGF act on VEGF receptors expressed by smooth muscle cells (Arrow 2). In addition,
we propose that chronic hypoxia increases expression of smooth muscle VEGF receptors
(Arrow 3). Finally, we propose that activation of smooth muscle VEGF receptors leads
to changes in contractile protein abundance and organization that result in changes in
arterial structure and function (Arrow 4). In this manner, we propose that hypoxic
increases in VEGF mediate not only microcirculatory angiogenesis, but also arterial
remodeling. Separate experiments were performed to test each of the numbered arrows
in fetal arteries.
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Materials and Methods
All techniques, protocols and procedures used in these studies received approval
from the Animal Research Committee of Loma Linda University and complied with all
policies and codes of practice outlined in the National Institutes of Health Guide for the
Care and Use of Laboratory Animals. Procedures related to tissue harvesting, tissue
preparation and animal surgery have been previously described in detail (54).

Tissue Harvest and Preparation
All experiments used common carotid arteries harvested from term fetal lambs (139
– 142 days gestation) delivered by Caesarian using strict sterile techniques. Pregnant
ewes were anesthetized with 30 mg/kg pentobarbital, intubated and maintained on 1.52.0% halothane. The fetus was subsequently exteriorized via a midline vertical incision
and killed by exsanguination via rapid removal of the heart. Normoxic arteries (FN)
were harvested from animals maintained at sea level whereas hypoxic arteries (FH) were
harvested from animals acclimatized at altitude (3820m above sea level) for the final 110
days of gestation, as previously described in detail (26, 32). This chronic hypoxia model
yields arterial oxygen tensions (PaO2) of 19±1 Torr in fetal sheep (26). Corresponding
normoxic arterial oxygen tensions average 23±1 Torr. Harvested common carotid arteries
were kept in sterile HEPES buffer solution composed of (in mM) 122.1 NaCl, 25
HEPES, 5.16 KCl, 2.4 MgSO4, 11.1 dextrose, 1.6 CaCl2 and 50 µM EDTA. After a
thorough and careful removal of the loose connective tissues and blood, the arteries were
denuded of endothelium via mechanical abrasion. Next, 3 mm lengths of artery were cut
and distributed to the various experimental protocols. Medial thicknesses and exact
arterial segment length measurements were completed using an Olympus U-PMTVC
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Optical microscope mounted with a Scion Visicapture Twain 1394 Camera for image
capture with ImagePro software (v6.0, Media Cybernetics).

Contractility Studies
The 3-mm arterial segments were mounted on tungsten wires between isometric
force transducers and micrometers used for precise positioning. Each artery was
equilibrated for one hour in calcium replete Na+-Krebs buffer (pH 7.4) containing (in
mM): 122 NaCl, 25.6 NaHCO3, 5.17 KCl, 2.56 dextrose, 2.49 MgSO4, 1.60 CaCl2, 0.114
ascorbic acid and 0.027 EGTA. Artery viability was preserved by diffusional oxygen
supply enabled by continuous bubbling with 95% O2 with 5% CO2 at normal ovine core
temperature (38 oC) (40). Unstressed artery diameters were measured immediately
following equilibration at a passive tension of 0.03 g. Relative to unstressed diameters
(D0), working diameters (D) required to attain arterial strain ratios (D/D0) of 1.5, 1.8, 2.1,
2.3, 2.7, 3.0 and 3.3 were calculated. Under resting conditions and after addition of high
potassium buffer solutions, contractile stresses (dynes/cm2) were measured at each of the
strain ratios to determine spontaneous myogenic tone and potassium-induced active tone
respectively. The constituents of the high potassium Krebs solution were (in mM) 122
KCl, 11.1 dextrose, 5.16 NaCl, 2.50 MgSO4, 2.15 NaHCO3, 1.60 CaCl2, 0.114 ascorbic
acid and 0.027 EDTA. Contractile responses to high potassium were recorded until
stabilized after which the arteries were returned to basal conditions using Na+-Krebs
buffer and then were equilibrated at the next stretch ratio. After responses were recorded
at the highest strain ratios, the arterial segments were frozen in liquid nitrogen to
eliminate any active component of stress (7, 40). The segments were subsequently
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incubated in calcium depleted Na+-Krebs containing 3 mM EGTA. Passive stresses
produced at each strain ratio from the highest to lowest were then recorded.
Differences between spontaneous tone measured before and after freezing with
liquid nitrogen and EGTA at each level of strain were taken as spontaneous myogenic
tone. Stiffness coefficients were determined by assessing the relations between strain
ratios and passive stresses using non-linear regression fits to a monotonic exponential
model (Young’s modulus) (13).

Fluorescent Immunohistochemistry
Segments of common carotid arteries were fixed overnight in 4% neutral buffered
EM-grade formaldehyde (Electron Microscopy Sciences, Hatfield, #15713S), paraffin
embedded and sectioned at 5 µm. Slides were deparaffinized in Histoclear solution
(National Diagnostic, Atlanta, #HS-200) and rehydrated in descending concentrations of
alcohol. The samples were microwaved in citrate buffer (pH 6.03) to recover antigenicity
after which the sections were permeabilized in 0.1%Triton X-100 (Sigma Aldrich, St
Louis, #T-8787) and then incubated in 1% Bovine Serum Albumin (Santa Cruz
Biotechnology, Santa Cruz, #SC-2323) to block non-specific binding. Incubations with
primary antibodies were carried out overnight at 4 oC. Antibody selectivity was
confirmed with Western blots and the titers used for IHC were the lowest that optimized
signal to noise ratio. The primary antibodies used included monoclonal anti-SMαA
(Sigma Aldrich, St Louis, A5228) @1:200, polyclonal anti-SMαA (abcam, ab5694)
@1:200, polyclonal anti-MLCK (Santa Cruz Biotechnology, Santa Cruz, SC-25428) @
1:50 and monoclonal anti-MLC20 (Sigma-Aldrich, St Louis, #M4401) @ 1:300. Slides
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were washed in PBS for two 10-minute cycles on the morning of the next day before the
secondary antibody (DyLight 488 Conjugated – Pierce Chemical, Rockford, #35502) was
applied to the tissues on the slides for two hours at room temperature. Keeping the slides
in the dark post-incubation preserved photosensitivity. The slides were subsequently
covered and washed for two 10-minute cycles in PBS. SlowFade Gold anti-fade reagent
with DAPI was then added and the slides were coverslipped and stored in the dark until
imaged. Tissue slides were imaged using a Zeiss Imager A1 on an AX10 Fluorescence
microscope with Spot software (Diagnostic Instruments, Inc. Ver. 4.6.4.5).

Confocal Microscopy
Artery sections of 5 µm thicknesses were double-stained with antibodies against
MLCK and SMαA as described in the “Fluorescent Immunohistochemistry” section.
Following primary antibody incubation, the sections were washed in PBS and
equilibrated in a dark room with two secondary antibodies labeled with Dylight – 488
(SMαA) and 649 (MLCK) for two hours at room temperature. The sections were imaged
with an Olympus FV1000 at an optical section thickness of 700 nm, a lateral resolution of
200 nm and a numerical aperture of 18. The extent of colocalization between the two
markers was determined using a custom-written non-parametric quadrant analysis that
calculated the fraction of total pixels in the upper half of the intensity range for both
markers relative to the number of pixels in the upper half of the intensity range for
SMαA. We refer to this index as the percentage of pixels in the upper right quadrant
(%UR). This method of quadrant analysis was adapted from flow-cytometry theory (1,
2) and has been described previously (9, 21). Double staining was also done on 5 µm
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sections on slides for MLC20 with SMαA and MLCK with MLC20. Primary antibodies
used were monoclonal anti-MLC20 (Sigma-Aldrich, St Louis, #M4401) @ 1:300 for
MLC20, monoclonal anti- SMαA (Sigma Aldrich, St Louis, A5228) @ 1:200 for SMαA
and polyclonal MYLK (Santa Cruz Biotechnology, Santa Cruz, SC -25428) @ 1:50 for
MLCK. Secondary antibodies for MLC20 colocalization with SMαA (DyLight 488 SMαA and 633 -MLC20) and for MLCK colocalization with MLC20 (Dylight 488 -MLC20
and 633 -MLCK) (Conjugated – Pierce Chemical, Rockford, #35502) were applied to the
tissues after which the sections were imaged as earlier described under “Fluorescent
Immunohistochemistry”.

Western Blotting
Known weights of frozen arterial segments were homogenized via glass-on-glass in
8M Urea containing (in mM) 500 NaCl, 20 Tris, 23 Glycine, 10 EGTA and 10% Glycerol
at pH 8.6 with protease inhibitor cocktail at 5 µl/ml of buffer (Sigma-Aldrich, Saint
Louis, #M1745). Centrifugation of the homogenates at 5,000G for 20 min yielded
supernatants whose protein concentrations were determined by the Bio-Rad Bradford
assay. Protein homogenates were separated via SDS-PAGE together with increasing
concentrations of standards used to calibrate target protein abundance. The tissues for the
standards were harvested from pooled adult ovine common carotid arteries. SDS-PAGE
separated proteins were transferred onto nitrocellulose membranes at 200 mA for 90
minutes in Towbin’s buffer (25 mM Tris, 192 mM Glycine, 10% and 20% Methanol) on
ice. Using 5% milk in Tris buffered saline at pH 7.5 (M-TBS); the membranes were
blocked for 1h at room temperature using continuous gentle shaking. After the initial

36

blocking, subsequent washes and incubations were done in M-TBS containing 0.1%
Tween-20. Incubations with primary antibody were performed for 3 hours using the
following dilutions for SMαA (1:3000), MLCK (1:10,000) and MLC20 (1:200) and
VEGF-A165 (1:750). All antibodies were obtained from same sources as described under
the immunohistochemistry section except for anti-VEGF antibody that was purchased
from Abcam (Cambridge, #AB119). Visualization was performed after a 90-minute
secondary incubation using a secondary antibody conjugated to Dylight 800 (Pierce
Chemical, Rockford, #46422). Imaging was completed on a LI-COR Bioscience Odyssey
system.
For the VEGF receptor Western blot assay, artery segments were homogenized
using a glass pestle and mortar containing buffer with (in mM) 500 NaCl, 50 Tris, and 5
EDTA at pH 7.4 with protease inhibitors including (in µM) 500 AEBSF, 400 pepstatinA, 20 bestatin, 10 E-64, 7.5 leupeptin, and 7 aprotinin (Sigma-Aldrich, Saint Louis, MO)
at 1:50 tissue buffer ratio. Homogenates were centrifuged at 100,000 XG for 1hr at 4 oC.
Pellets were resuspended at a 1:10 tissue buffer ratio with (in mM) 150 NaCl, 50 Tris, 10
DTT and 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.2% SDS and 10% Glycerol
with protease inhibitor cocktail as above for 1hr with gentle shaking at room temperature.
Samples were ultra-sonicated 6 x 5 sec at 20% amplitude to shear DNA, centrifuged at
10,000 XG for 15 min after which the supernatants were collected. Protein
concentrations were determined using Bradford’s protein assay. Protein homogenates
were separated on 5% SDS-PAGE with addition of 35 mM β-mercaptoethanol (BME) in
the upper buffer reservoir, along with a pooled reference to normalize samples.
Separated proteins were transferred onto 0.2 µm nitrocellulose (Whatman, BA83) using
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350 mA for 90 min in Towbin's buffer containing (in mM) 25 Tris, 35 BME, 192
Glycine, 0.01% SDS and 20% Methanol. Following transfer, the membranes were
blocked in 5% milk with Tris-buffered saline at pH 7.5 (M-TBS) for 1 hour at room
temperature using continuous shaking. All subsequent washes and incubations were
performed in M-TBS with 0.1% Tween-20 included. Primary antibodies were incubated
for 3 hours with the following dilutions for Fms-like tyrosine kinase receptor (Flt-1 ) at
1:200 (SC-316) and Fetal Liver Kinase 1 (Flk-1) at 1:200 (SC-504) from Santa Cruz.
Membranes were washed 6 X 5min followed by a 90 min incubation of secondary
antibody conjugated to DyLight 800 (Pierce Chemical, Rockford, IL). Membranes were
washed 6 X 5min then washed in TBS only. Membranes were imaged on LI-COR
Bioscience’s Odyssey system.

Organ Culture
As previously described (7), serial segments of individual arteries from both
experimental groups (FN and FH) were maintained in Dulbecco’s Modified Eagle Media
(DMEM) fortified with 3.7 g/l of Na2HCO3, 0.5% amino acid solution (Sigma Aldrich,
St. Louis, #M5550), 1% non-essential amino acid solution (Sigma Aldrich, St Louis,
#M7145), 4 mM glutamine (Sigma Aldrich, St. Louis, #G7513), 2% antibioticantimycotic solution (Gibco, Carlsbad, #15240-096), and 70 µg/ml of Gentamycin
(Gibco, Carlsbad, #15750-060) in an untreated 12-well plate, and subsequently
maintained in a humidified incubator with 5% CO2 in room air at 37 oC. Matched sets of
artery segments left in DMEM media for 24 hrs served as control arteries while those
treated with low dose (3 ng/ml) of VEGF were used to assess the effects of VEGF.
Segments treated with vatalanib (240 nM) and dasatinib (6.3 nM) (42) were used to
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assess the effects of VEGF tyrosine kinase receptors; the concentrations used were
identified as the lowest effective concentrations in preliminary dose-finding experiments.
In all organ culture experiments, the artery segments were first maintained in media
without growth factors (DMEM) for 24hrs. Control arteries remained in DMEM for
another 24 h, and treated arteries were exposed to 3 ng/ml VEGF for 24 hours. This low
dose of VEGF was used to minimize non-specific binding of VEGF to other non-VEGF
receptors and represented physiological serum levels measured in gravid sheep (52).

Data Analysis and Statistics
Contractile stresses generated from applied graded strains were calculated as ratios
of force per cross-sectional area where force equals tension measured in grams multiplied
by acceleration due to gravity, and cross sectional area equals working wall thickness
(µm) multiplied by segment length. Each animal used contributed to the fresh, control,
VEGF and VEGF+vatalanib+dasatinib groups. Contractile stress measurements,
thicknesses and stiffness values were compared using analysis of variance (ANOVA). All
data sets were confirmed to be normally distributed using the D'Agostino-Pearson
analysis, and homogeneity of variance within ANOVA was verified using a Bartlett’sCochran test as previously described (9). Statistical power was routinely at least 0.8.
All Western immune blot measurements were calibrated against a standard curve
generated from a pooled reference of common carotid tissues. Regional abundance values
were compared using a 2-way analysis of variance (ANOVA) with age and treatment as
variables. Duncan’s Multiple Range analysis was used to make post-hoc comparisons
between means within the ANOVA.
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Results
The study is based on a total of 124 segments from 17 normoxic fetal lambs and 93
segments from 12 hypoxic fetal lambs. In all cases, “n” indicates the number of animals
used. Statistical significance implies P<0.05. All values are presented as mean ± SEM.

Effects of Chronic Hypoxia on Carotid Artery Structure and StressStrain Relations
Medial thicknesses in fresh normoxic arteries (341±20 µm) were significantly less
than in fresh hypoxic arteries (400±28 µm) (Figure 2); chronic hypoxia significantly
increased medial thicknesses by 17%. Similarly, arterial stiffness values in fresh
normoxic arteries (8.02±0.42) were significantly less than stiffness values in fresh
hypoxic arteries (9.20±0.69) (Figure 2); hypoxic increases in stiffness averaged to 15%.
Peak myogenic tone averaged 102.5±21.8 dynes/cm2 in normoxic fetal arteries but only
25.9±6.3 dynes/cm2 in hypoxic arteries. On average, chronic hypoxia significantly
decreased peak myogenic tone by 75%.
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Figure 2: Hypoxia remodels ovine carotid artery structure and function. When compared
to normoxic arteries, arteries from chronically hypoxic animals exhibited an increased
thickness of the medial layer (left panel) and also increased stiffness (middle panel).
Determination of active stress-strain relations revealed that chronic hypoxia also
significantly depressed myogenic tone but did not alter the strain values at which
contractile force was maximal. Results are presented as mean ± SEM for arteries from
normoxic (n =17) and hypoxic (n=12) fetuses. Significant differences denoted by
asterisks (*) imply P <0.05.
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Effects of Chronic Hypoxia on Contractile Protein Abundance and
Colocalization
The effects of chronic hypoxia on contractile protein abundances were highly
protein specific (Figure 3). For SMαA, Western blot quantification revealed similar
abundances (relative to standard) in both normoxic (0.62±0.07) and hypoxic arteries
(0.68±0.08). For MLCK, abundances were 90% less in hypoxic than in normoxic arteries.
In contrast, hypoxic abundances of MLC20 were 61% greater than in normoxic arteries.
Chronic hypoxia significantly increased colocalization among all three pairs of
contractile proteins examined (Figure 4). For MLCK- SMαA, chronic hypoxia increased
the coefficient of colocalization 42% relative to the normoxic group. Corresponding
increases for MLC20 - SMαA and MLCK-MLC20 colocalization averaged 123% and
237%, respectively.
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Figure 3: Chronic hypoxia alters smooth muscle contractile protein abundances. Western
blot quantification of SMαA abundance yielded similar values in normoxic and hypoxic
fetal carotid arteries (Left Panel). For MLCK abundance, the values were markedly less
in hypoxic than in normoxic arteries. In contrast, MLC20 abundances were significantly
greater in hypoxic than in normoxic arteries. These results demonstrate that the effects
of chronic hypoxia on smooth muscle contractile protein abundances are highly protein
specific. Results are presented as mean ± SEM for n≥5 in all experimental groups.
Significant differences denoted by asterisks (*) imply P<0.05 via ANOVA.
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Figure 4: Chronic hypoxia increases colocalization among smooth muscle contractile
proteins. As revealed by confocal microscopy, colocalization of MLCK with SMαA was
42% greater in hypoxic than normoxic fetal arteries. Similarly, colocalization of MLC20
with SMαA was 42% greater, and colocalization of MLCK with MLC20 was 123%
greater, in hypoxic than in normoxic fetal arteries. All these differences were statistically
significant and suggest that the contractile proteins were becoming more compact and
highly organized in response to chronic hypoxia. Results are presented as mean ± SEM
for n≥5 in all experimental groups. Significant differences denoted by asterisks (*) imply
P<0.05 via ANOVA.
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Effects of Long-term Hypoxia on Abundances of VEGF and VEGF
Receptors
Western blot quantification of endogenous VEGF levels in FN (0.29±0.07) and
FH arteries (0.25±0.06) revealed similar VEGF abundances (Figure 5), suggesting that
hypoxia had little effect on VEGF levels after 110 days of hypoxic acclimatization. In
contrast, the abundances of the endogenous VEGF receptors 1 (flt-1) and 2 (flk-1) were
786% and 171% greater in chronically hypoxic fetal arteries than in normoxic fetal
arteries (Figure 6).
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Figure 5: Effects of long-term hypoxia on VEGF abundance. Endogenous VEGF levels
quantified via western blot analysis exhibited similar abundances in normoxic and
hypoxic fetal sheep. These results suggest that the well-documented increases in VEGF
induced upon exposure to hypoxia are transient and disappear after 110 days of hypoxic
acclimatization. Results are presented as mean ± SEM for arteries from normoxic (n=7)
and hypoxic (n=5) fetal arteries.
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Figure 6: Effects of long-term hypoxia on VEGF receptor expression. In homogenized
endothelium-denuded fetal arteries, abundances of VEGF receptor 1 (Flt-1) and VEGF
receptor 2 (Flk-1) were significantly increased by chronic hypoxia. The multiple bands
indicated on the western blots (lower panel) indicate the different glycosylation states of
the receptors. The results shown in the bar charts (upper panel) represent the total of all
glycosylation states for Flk-1. Due to the absence of the 230 kD form of Flt-1 in hypoxic
arteries (lower panel), the bar charts compare abundances of the 250 kD form. The
standards shown on the western blots were prepared from mixed samples of normoxic
adult arteries. Results are presented as mean ± SEM for n=6 in all experimental groups.
Significant differences denoted by asterisks (*) imply P<0.05 via ANOVA.
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VEGF Receptors Mediate VEGF-induced Changes in Contractile
Protein Organization
To confirm that VEGF altered contractile protein organization through a VEGF
receptor-dependent mechanism, MLC20-SMαA colocalization was used as a reporter
assay (Figure 7). In organ culture, a low physiological concentration (3 ng/ml) of VEGF
increased the colocalization of MLC20 with SMαA by 237%. This effect of VEGF was
blocked completely in the presence of the VEGF receptor blockers vatalanib (240 nM)
and dasatanib (6.3 nM).
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Figure 7: VEGF activation of its tyrosine kinase receptors mediates increased contractile
protein colocalization. Organ culture of endothelium-denuded normoxic fetal arteries
with VEGF (3ng/ml) significantly increased colocalization of MLC20 with SMαA.
Addition of the VEGF receptor antagonists vatalanib (240nM) and dasatinib (6.3nM)
completely blocked this effect of VEGF. Results are presented as mean ± SEM for n = 5
in all experimental groups. Significant differences denoted by (*) imply P<0.05 via
ANOVA.
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Effects of VEGF on Contractile Protein Abundance and Colocalization
In organ culture, treatment with 3 ng/ml VEGF had no significant effect on SMαA
abundances in either normoxic (0.59±0.05 vs. 0.64±0.07) or hypoxic (0.66±0.07 vs.
0.64±0.09) fetal arteries (Figure 8). For MLCK however, VEGF significantly increased
MLCK abundances in normoxic arteries by 100% but decreased them in hypoxic arteries
by 33%; following VEGF treatment MLCK abundances were significantly greater in
normoxic than hypoxic arteries. For MLC20, VEGF had no individually significant effect
in normoxic (0.23±0.04 vs.0.27±0.05) or hypoxic arteries (0.38±0.03 vs.0.44±0.08), but
after treatment with VEGF, MLC20 abundances were significantly less in normoxic than
hypoxic arteries. As indicated by comparison of Figures 3 and 8, chronic hypoxia and
VEGF had highly similar effects on the abundances of all three contractile proteins.
The effects of VEGF and chronic hypoxia on patterns of contractile protein
colocalization were also highly similar. In parallel with the effects of chronic hypoxia
(Figure 4), organ culture with 3 ng/ml VEGF increased colocalization of MLCK and
SMαA by 55%, increased colocalization of MLC20 with SMαA by 237%, and increased
colocalization of MLCK with MLC20 by 75% (Figure 9). All of these effects of VEGF
on contractile protein colocalization were statistically significant.
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Figure 8: Effects of VEGF on contractile protein abundances are highly protein specific
As revealed by western blot quantification, organ culture with 3 ng/ml VEGF had no
significant effect on SMαA abundance in endothelium-denuded arteries from either
normoxic or hypoxic fetuses. In contrast, organ culture with 3 ng/ml VEGF significantly
increased MLCK abundance in endothelium-denuded arteries from normoxic fetuses, but
decreased it in arteries from hypoxic fetuses. Conversely, organ culture with 3 ng/ml
VEGF had no significant effect on MLC20 abundance in arteries from normoxic fetuses,
but significantly increased MLC20 in arteries from hypoxic fetuses. This pattern of
effects emphasizes that the effects of VEGF on contractile protein abundance are highly
protein specific, are markedly influenced by hypoxic acclimatization, and are closely
similar to the effects of chronic hypoxia (Figure 3). Results are presented as mean ±
SEM for n = 5 in all experimental groups. Significant differences denoted by asterisks (*)
imply P<0.05 via ANOVA.
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Figure 9: VEGF increases colocalization among smooth muscle contractile proteins
In endothelium-denuded arteries from normoxic fetuses, organ culture of with 3 ng/ml
VEGF increased colocalization of MLCK with SMαA by 55%, MLC20 with SMαA by
237%, and MLCK with MLC20 by 75%, compared to corresponding untreated controls.
These results demonstrate that VEGF can act directly on arterial smooth muscle to
enhance contractile protein colocalization. This pattern of effects was also closely
similar to the effects of chronic hypoxia on contractile protein colocalization (Figure 4).
Results are presented as mean ± SEM for n≥5 in all experimental groups. Significant
differences denoted by (*) imply P<0.05 via ANOVA.
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Discussion
This study offers three original findings suggesting a non-angiogenic role of VEGF
in hypoxic remodeling of fetal ovine carotid arteries. First, in homogenates of
endothelium-denuded fetal carotids, 110 days of hypoxic acclimatization had no effect on
VEGF levels but significantly increased abundances of both main VEGF receptors (Flt-1
and Flk-1), relative to normoxic controls. Second, both chronic hypoxia and organ
culture with VEGF were without effect on SMαA, decreased MLCK, and increased
MLC20 abundances in endothelium-denuded fetal carotids. Third, both chronic hypoxia
and organ culture with VEGF increased colocalization of MLCK with SMαA, MLC20
with SMαA, and MLCK with MLC20. Together, these findings support the general
hypothesis that VEGF contributes to hypoxic fetal vascular remodeling through changes
in the abundance, organization and function of contractile proteins.

Effects of Hypoxia on Structure and Contractility
Previous studies of hypoxic vascular remodeling have reported hypoxic increases in
total arterial wall thickness involving both the medial and adventitial layers (17, 37, 47).
In the present study, chronic hypoxia increased medial thicknesses (Figure 2), reinforcing
the view that hypoxia promotes expansion of arterial smooth muscle (11, 47), an
important determinant of overall arterial stiffness. Correspondingly, hypoxia also
increased arterial stiffness, suggesting altered smooth muscle composition and structure
(31) and possibly increased collagen cross-linking and collagen-to-elastin ratios (53). The
associated hypoxic decreases in contractile stresses, measured in units of dynes/cm2
(Figure 2), suggest that hypoxia increased the ratio of non-contractile to contractile
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proteins in the artery wall in these fetal ovine carotid arteries (7, 17). Such changes were
probably mediated by a unique but unknown combination of numerous possible
mechanisms (31).
Consistent with previous studies (17), hypoxic structural changes in the fetal
arteries were associated with decreased myogenic reactivity (Figure 2). Hypoxic
depression of myogenic tone must involve changes in either regulation of cytosolic
calcium or myofilament calcium sensitivity (34, 41). Whereas effects of chronic hypoxia
on calcium signaling in non-pulmonary smooth muscle remain largely unreported,
evidence from our group suggests that chronic hypoxia significantly alters myofilament
calcium sensitivity in ovine cranial arteries (35). Correspondingly, the present study
explored the hypothesis that hypoxia may alter myofilament calcium sensitivity and
contractility through changes in contractile protein abundance and organization.

Effects of Hypoxia on Contractile Protein Abundances
The most abundant contractile protein in smooth muscle is SMαA, a ≈42 kDa
monomer that polymerizes to form the thin filaments essential for contraction (38).
Expression of SMαA did not differ significantly from normoxic basal levels after
hypoxic acclimatization for 110 days (Figure 3, Left) suggesting that the signaling
pathways that govern expression of this contractile protein were not altered by hypoxia.
Another contractile protein whose expression varies with smooth muscle phenotype
is MLCK (4, 7, 22), the rate-limiting enzyme that phosphorylates and activates regulatory
MLC20 (19). Hypoxia potently decreased MLCK (Figure 2, Middle), due possibly to
phenotypic transformation or an effect at the level of transcription, translation, or
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turnover. For transcription, hypoxia might act through HIF-1α to activate an HRE that
decreases MLCK gene transcription. No evidence for a repressor element in the MLCK
gene has yet been published, although Qi (44) has reported that HIF can upregulate
MLCK expression in cultured pulmonary vein endothelial cells suggesting the possible
presence of an HRE in the MLCK promoter. Alternatively, hypoxia might enhance
MLCK degradation; MLCK abundance dropped precipitously in arteries organ cultured
under serum-starved conditions (7). This drop in MLCK would require rapid degradation,
which might be stimulated by hypoxia (28). Hypoxia might also drive phenotypic
transformation toward a less contractile, more synthetic phenotype that expresses less
MLCK (19). Hypoxia’s ability to promote such transformation has been demonstrated in
cultured rat pulmonary artery smooth muscle (23, 57), but not previously in whole
arteries adapted to chronic hypoxia.
In sharp contrast to the pattern of change observed for MLCK, MLC20 abundances
significantly increased in hypoxic compared to normoxic arteries (Figure 3, Right).
Although hypoxic increases in MLC20 abundance could result from increased
transcription due to an HRE in the promoter for MLC20, literature searches yielded no
evidence of an HRE in the promoters for MLC20 or myosin heavy chain with which
MLC20 should be co-expressed (14). Hypoxic increases in MLC20 abundance also might
result from increases in translation efficiency, but available evidence suggests only
inhibition of translation by hypoxia (33). Hypoxic increases in MLC20 might be
explained by phenotypic transformation toward a synthetic phenotype, which is
characteristic of hypoxia (21). Such a transformation would increase MLC20 as a
component of increased Non-Muscle MHC expression, which is induced by chronic
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hypoxia in fetal carotid arteries (21). In light of evidence that hypoxia can increase
protein degradation (45), this mechanism might also contribute to hypoxic increases in
MLC20 abundance. Equally important, the diverse effects of hypoxia on SMαA, MLCK,
and MLC20 abundances emphasize that the effects of hypoxia on contractile protein
expression are unique and highly specific for each protein.

Effects of Hypoxia on Contractile Protein Organization
Vascular contractility is determined not only by contractile protein abundances, but
also by protein organization within smooth muscle cells (6). Chronic hypoxia increased
colocalization of MLCK with SMαA (Figure 4, Left) suggesting that hypoxia depressed
release of an inhibitory factor, or enhanced release of a stimulatory factor, from either the
endothelium or adventitia to enhance MLCK-SMαA colocalization. Although the
molecular mechanisms responsible remain unknown, this result is consistent with
evidence that MLCK binds strongly with SMαA (29) through mechanisms that are
physiologically regulated (6).
As for colocalization of MLCK with SMαA, hypoxia also enhanced colocalization
of MLC20 with SMαA (Figure 4, Middle) and colocalization of MLCK with MLC20
(Figure 4, Right), demonstrating that hypoxia orchestrated processes that enhanced
interaction among multiple contractile proteins. Importantly, this pattern of increased
colocalization occurred concurrently with markedly decreased MLCK abundance (Figure
3), which raises the possibility that increased colocalization may help preserve hypoxic
contractility (Figure 2). Together, these results emphasize that hypoxia exerts
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coordinated but separate influences on contractile protein abundance, organization, and
function through mechanisms that remain largely unidentified.
Effects of Chronic Hypoxia on VEGF and VEGF Receptors
To better understand the mechanisms that mediate the effects of hypoxia on
contractile protein abundance, organization, and function we studied established
mediators of hypoxic effects. The most prominent of these is hypoxia inducible factor
(HIF) (46, 56), which is well known to increase capillary angiogenesis through induction
of VEGF (18). In light of recent evidence from our laboratory that VEGF can act directly
on arterial smooth muscle to alter phenotype, contractile protein expression and
contractility (7, 21), we formulated the hypothesis that VEGF contributes to hypoxic fetal
vascular remodeling through changes in the abundance, organization and function of
contractile proteins (Figure 1). Our first test of this hypothesis (Figure 1, Arrow 1) was
to examine the effects of 110 days of hypoxia on VEGF levels in endothelium-denuded
fetal carotid homogenates. VEGF levels were unchanged by chronic hypoxia (Figure 5),
in agreement with previous reports that VEGF rises then returns to baseline within 21
days of chronic hypoxia (10). In addition, this finding also suggested that elevated VEGF
could not explain the sustained changes in contractile protein abundance and
colocalization observed in hypoxic arteries.
In light of evidence that hypoxia can modulate levels of VEGF receptors in the
vascular endothelium and certain tumors of rodent brain (43, 50), we also tested the
possibility that chronic hypoxia increased VEGF receptor levels in fetal arterial smooth
muscle (Figure 1, Arrow 3). These measurements yielded the novel finding that both
main VEGF receptors (Flk-1 and Flt-1) were expressed in fetal ovine carotid arteries, as
suggested by previous measurements of VEGF receptor mRNA (7). More importantly,
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these measurements revealed that chronic hypoxia significantly enhanced VEGF receptor
abundances (Figure 6). Together with our VEGF measurements (Figure 5), these
findings support the novel view that hypoxia promotes VEGF-mediated effects in the
short term through increases in VEGF abundance (10), but in the long term through
increases in the abundances of VEGF receptors.

Effects of VEGF on Contractile Protein Abundance and Organization
To confirm that our previously reported effects of VEGF on contractile proteins in
fetal lamb carotids (7, 21) were mediated by action on smooth muscle VEGF receptors
(Figure 1, Arrow 2), we examined the effects of VEGF on colocalization of MLC20 with
SMαA in the presence and absence of vatalanib and dasatinib, two well-characterized
VEGF receptor antagonists (27, 42). Organ culture of endothelium-denuded fetal carotid
arteries with a low physiological concentration (3 ng/ml) of VEGF (7, 52) significantly
increased colocalization of MLC20 with SMαA (Figure 7). At concentrations found to be
optimal in previous dose-finding experiments (21), vatalanib at 240 nM with dasatinib at
6.3 nM in coculture with VEGF completely blocked the effects of VEGF on
colocalization of MLC20 with SMαA. These results thus verified that VEGF can act
through VEGF receptors to alter contractile protein organization in fetal carotid arteries.
As a further test of the hypothesis that VEGF contributes to hypoxic vascular
remodeling, our next series of experiments examined the effects of VEGF on contractile
protein abundances (Figure 1, Arrow 4). Organ culture with a physiological
concentration (3 ng/ml) of VEGF (52) had no effect on SMαA abundance, significantly
depressed MLCK abundance and significantly increased MLC20 abundance, in hypoxic
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relative to normoxic arteries (Figure 8). Most importantly, this pattern of effects was
closely similar to the effects of chronic hypoxia on the same contractile proteins in fresh
arteries. When we examined the effects of organ culture with VEGF on contractile
protein colocalization, VEGF increased colocalization of MLCK with SMαA, of MLC20
with SMαA, and of MLCK with MLC20. Again this pattern of effects was quite similar
to the effects of chronic hypoxia on contractile protein colocalization. Together, these
abundance and colocalization measurements support the hypothesis that VEGF
contributes to hypoxic fetal vascular remodeling through changes in the abundance,
organization and function of contractile proteins.
To confirm that our previously reported effects of VEGF on contractile proteins in
fetal lamb carotids (7, 21) were mediated by action on smooth muscle VEGF receptors
(Figure 1, Arrow 2), we examined the effects of VEGF on colocalization of MLC20 with
SMαA in the presence and absence of vatalanib and dasatinib, two well-characterized
VEGF receptor antagonists (27, 42). Organ culture of endothelium-denuded fetal carotid
arteries with a low physiological concentration (3 ng/ml) of VEGF (7, 52) significantly
increased colocalization of MLC20 with SMαA (Figure 7). At concentrations found to be
optimal in previous dose-finding experiments (21), vatalanib at 240 nM with dasatinib at
6.3 nM in coculture with VEGF completely blocked the effects of VEGF on
colocalization of MLC20 with SMαA. These results thus verified that VEGF can act
through VEGF receptors to alter contractile protein organization in fetal carotid arteries.
As a further test of the hypothesis that VEGF contributes to hypoxic vascular
remodeling, our next series of experiments examined the effects of VEGF on contractile
protein abundances (Figure 1, Arrow 4). Organ culture with a physiological
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concentration (3 ng/ml) of VEGF (52) had no effect on SMαA abundance, significantly
depressed MLCK abundance and significantly increased MLC20 abundance, in hypoxic
relative to normoxic arteries (Figure 8). Most importantly, this pattern of effects was
closely similar to the effects of chronic hypoxia on the same contractile proteins in fresh
arteries. When we examined the effects of organ culture with VEGF on contractile
protein colocalization, VEGF increased colocalization of MLCK with SMαA, of MLC20
with SMαA, and of MLCK with MLC20. Again this pattern of effects was quite similar
to the effects of chronic hypoxia on contractile protein colocalization. Together, these
abundance and colocalization measurements support the hypothesis that VEGF
contributes to hypoxic fetal vascular remodeling through changes in the abundance,
organization and function of contractile proteins.

Overview
The present study explores the mechanisms that couple chronic hypoxia to changes
in the structure and function of large systemic fetal arteries (Figure 1). Consistent with
numerous previous studies (21, 32), our findings demonstrate that chronic hypoxia alters
fetal artery structure and contractility (Figure 2). A diverse and abundant literature also
supports the idea that hypoxia potently increases VEGF in the short-term (10, 46). The
present study expands this concept by demonstrating that in the long term, chronic
hypoxia has little effect on VEGF (Figure 5) but potently increases the VEGF receptor
abundances (Figure 6). Our results also augment previous findings that VEGF can
modulate the expression, organization and function of smooth muscle contractile proteins
(7, 21), by demonstrating that these effects are dependent on activation of smooth muscle
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VEGF receptors (Figure 7). Finally, the present study demonstrates that the qualitative
effects of chronic hypoxia on the abundance (Figure 3) and colocalization (Figure 4) of
SMαA, MLCK, and MLC20 are closely similar to the corresponding effects of VEGF
(Figures 8 and 9). Together with the other evidence obtained, the findings as a whole are
highly consistent with the general hypothesis that VEGF contributes to hypoxic fetal
vascular remodeling through changes in the abundance, organization and function of
contractile proteins. Without doubt, VEGF is not the only factor contributing to hypoxic
vascular remodeling (5), and future in vivo studies that involve selective interruption of
VEGF signaling in large systemic arteries will be required to quantitatively assess the
role of VEGF in hypoxic vascular remodeling. The present findings suggest that such
future studies are warranted, and advance the idea that hypoxic increases in VEGF act
simultaneously in the microcirculation to increase capillary density, while also acting in
the large upstream arteries to alter the abundance, organization and function of contractile
proteins.
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Abstract
In response to hypoxia, Hypoxia inducible factor (HIF-1) in living cells induces
transcription of angiogenic genes; one of which is VEGF. Though principally known for
its regulation of angiogenesis and vasculogenesis, recent studies have suggested VEGF
involvement with hypoxic vascular remodeling. Many regard VEGF as a specific
mitogen for endothelial cells, which exert paracrine effects on other cell types but recent
studies provide evidence that VEGF exerts direct trophic effects on cells in the intima
layer of blood vessels. This current study explores the hypothesis that chronic hypoxia
produces a sustained increase in the density of vascular VEGF receptors, which in turn
helps mediate the long-term effects of hypoxia on adult ovine carotid arteries. Carotid
arteries from animals maintained at altitude for 110 days or at sea level were harvested
and denuded of endothelium. Fresh normoxic and hypoxic as well as organ cultured
segments in 3 ng/ml VEGF were used to test the effects of hypoxia and VEGF
respectively. Whereas VEGF levels were similar to basal levels after 110 days of
hypoxia, VEGF receptor levels were increased by 107% (flt-1) and 156% (flk-1). Also
VEGF replicated effects of hypoxia on SMαA and MLC20 abundances as well as MLC20
- SMαA colocalization. VEGF did not replicate hypoxic effects on MLCK abundance,
MLCK- SMαA colocalization and MLCK- MLC20 colocalization, suggesting that
postnatal development alters MLCK gene and its consequent reactivity to hypoxia and
VEGF. VEGF effects were potently inhibited by VEGF receptor blockers – vatalinib
(240 nM) and dasatinib (6.3 nM). Taken together, the current study supports the
hypothesis that long-term upregulation of VEGF receptors mediate hypoxic vascular
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remodeling through differential alteration of contractile protein abundance and
colocalization.

Key Words
Myosin Light Chain Kinase, Organ Culture, Regulatory Myosin Light Chain, Smooth
Muscle, VEGF

71

Introduction
Blood vessels regularly undergo structural changes in response to changing patterns
of endogenous and exogenous stimuli (4, 42, 50, 51). These continuous changes in blood
vessel cellular and extracellular structure are collectively known as remodeling and
enable functional adaptation and specialization (25, 46). Vascular remodeling serves both
normal physiologic adaptation, as with uterine artery remodeling during pregnancy (4),
and also with pathological remodeling, as occurs during atherosclerosis (48) and
tumorigenesis (8, 10, 35). Whereas vascular remodeling is clearly a prominent and
dynamic process in all vascular beds, the factors involved with its initiation and
maintenance remain largely unknown.
One of the most widely studied initiators of vascular remodeling is hypoxia, which
can promote both physiological (13) and pathological (19) changes in vessel structure and
function. Reduced oxygen availability can act through multiple pathways to alter the
phenotypic characteristics and contractile function of vascular smooth muscle, and
thereby optimize tissue perfusion and oxygenation (17, 24, 34, 57). Whereas a plethora of
evidence supports endothelial (33) and adventitial (14) expansion as major components
of vascular remodeling, more recent findings suggest that hypoxic remodeling also
involves the medial layer of the artery wall (24, 26). In addition, vascular remodeling
appears to involve not only myocytes in the medial layer, but also smooth muscle
progenitor cells that originate in the bone marrow, migrate to and reside in the adventitial
layer of the vessel wall, and then differentiate into myofibroblasts in the medial layer
(32). Another key feature of medial smooth muscle cells is that they retain remarkable
plasticity and can dedifferentiate from contractile cells into more synthetic, proliferative,
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and migratory phenotypes in response to many types of environmental stimuli (54). Not
surprisingly, smooth muscle phenotypic plasticity is particularly pronounced in term
fetuses and neonates and facilitates the rapid changes in vascular structure and function
that are characteristic of postnatal development (43). How hypoxia influences smooth
muscle plasticity and differentiation remains poorly understood, particularly in immature
blood vessels.
Efforts to better understand the mechanisms of hypoxic vascular remodeling have
strongly implicated the transcription factor HIF as a primary initiator of multiple gene
transcription events that coordinate responses to hypoxia and culminate in increased
production of erythropoietin, glycolytic enzymes and angiogenic factors (5, 39, 47). The
most important angiogenic factor induced by HIF is Vascular Endothelial Growth Factor
(VEGF), which directly stimulates angiogenesis and neovasculization through activation
of broadly distributed specific tyrosine kinase receptors (22). Interestingly, hypoxiainduced increases in VEGF typically attain peak values within 48 hours and then return
back to basal levels within three weeks of hypoxic exposure (28) (28). Despite the
transient nature of the transient responses of VEGF to hypoxia, the remodeling effects of
hypoxia can persist for many weeks and months (21, 29, 36). This pattern of vascular
responses to hypoxia raises multiple questions about the role of VEGF in long-term
hypoxic vascular remodeling. One possible explanation is that hypoxia promotes shortterm increases in VEGF, but long-term increases in VEGF receptors, as suggested to
occur in fetal ovine carotid arteries from ewes acclimatized at altitude for 110 days (1).
Consistent with this observation, other studies have also shown that hypoxia can increase
the density of VEGF receptors (flt-1 and flk-1) (3, 20, 53).
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In light of the published evidence, the current study explores the hypothesis that
chronic hypoxia produces a sustained increase in the density of vascular VEGF receptors,
which in turn helps mediate the long-term effects of hypoxia on vascular remodeling.
This hypothesis builds on our previous work demonstrating that VEGF can contribute to
hypoxic vascular remodeling of fetal arteries through alteration of contractile protein
abundances and colocalization (1, 9, 24). To test this hypothesis, the experimental
approach employed a well-established model of chronic hypoxia in which adult sheep
were rendered hypoxic by housing them at an altitude of 3820m for 110 days; normoxic
controls were maintained at sea level (30). Assessments of hypoxic changes in
composition and interactions among contractile protein focused on: 1) SMαA, which is
the most abundant contractile protein in smooth muscle cells (55); 2) regulatory Myosin
Light Chain (MLC20), which is a key regulator of contraction; and 3) Myosin Light Chain
Kinase (MLCK), which is the dedicated kinase that phosphorylates and activates MLC20
(16, 49). To assess the direct effects of VEGF on arterial wall remodeling, the
experimental approach included organ-culture with VEGF, as previously described in
detail (1, 9). Together, these experiments provided a unique perspective of the role of
VEGF and VEGF receptors in long-term hypoxic vascular remodeling.
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Materials and Methods
Protocols, techniques and procedures used in all animal experiments were approved
by the Animal Research Committee of Loma Linda University and also complied with
policies and codes of practice recommended by the National Institutes of Health in the
NIH-Guide for Care and Use of Laboratory Animals.

Tissue Harvest and Preparation
Common carotid arteries harvested from adult non-pregnant sheep were used in all
experiments. These sheep were sacrificed while fully anesthetized with 100 mg/kg
pentobarbital administered intravenously. Control animals (sheep maintained at sea level)
yielded normoxic arteries while sheep subjected to our chronic hypoxia model generated
hypoxic arteries. This model involves acclimatization of non-gravid sheep at altitude of
3280m above sea level thereby yielding arterial oxygen tension of 64±2 Torr in the
animals. Correspondingly normoxic arterial oxygen tensions equal 102±2 Torr.
Harvested arteries were kept in sterile HEPES buffer solution composed of (in mM)
122.1 NaCl, 25 HEPES, 5.16 KCl, 2.4 MgSO4, 11.1dextrose, 1.6 CaCl2 and 50 µM
EDTA. Loose parenchymal and adventitial tissue as well as blood was removed from the
arteries after which endothelial denudation was achieved via luminal mechanical
abrasion. All experimental protocols made use of segments 3mm length arterial
segments. Precise arterial length and medial thicknesses were determined using an
Olympus U-PMTVC Optical microscope mounted with a Scion Visicapture Twain 1394
Camera for image capture. ImagePro software (v6.0, Media Cybernetics) was used to
measure the variables from the images captured by the camera.
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Contractility Studies
For contractility measurements, artery segments measuring 3-mm in length were
mounted on paired tungsten wires between a low-compliance isometric force transducer
and a rod attached to a micrometer used for precise variation of resting tension. Each
segment was equilibrated at 38.5 oC (normal ovine core temperature) for one hour in
calcium replete Na bicarbonate Krebs solution (pH7.4) composed of (in mM) 122 NaCl,
25.6 NaHCO3, 5.17 KCl, 2.56 dextrose, 2.49 MgSO4, 1.60 CaCl2, 0.114 ascorbic acid
and 0.027 EGTA. Artery segments were kept viable by continuous bubbling of the
incubation buffer with 95% oxygen with 5% carbon IV oxide. Working diameters
denoted as (D) required to attain strain ratios of 1.5, 1.8, 2.1, 2.3, 2.7, 3.0 and 3.3 were
calculated relative to unstressed artery diameter, Do (measured at a passive tension of
0.03 g. Contractile responses at each stretch ratio to isotonic potassium Krebs composed
of (in mM) 122 KCl, 11.1 dextrose, 5.16 NaCl, 2.50 MgSO4, 2.15 NaHCO3, 1.60 CaCl2,
0.114 ascorbic acid and 0.027 EDTA, were recorded after equilibration in Na Krebs.
After each maximum contraction, arteries were washed and left to stabilize in Na Krebs
before the next stretch ratio was achieved. Once contractions in response to the highest
stretch ratio were recorded, the active component of the artery was eliminated by freezing
in liquid nitrogen and left to equilibrate in 3 mM EGTA solution. Passive arterial stresses
were subsequently measured at each strain ratio starting with the highest stretch ratio to
the lowest. Spontaneous myogenic tone was defined as the difference in tone generated
before and after freezing the artery segment while arterial stiffness was calculated from
the passive stresses using the Young’s modulus model as previously described.
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Fluorescent Immunohistochemistry
Freshly harvested as well as organ-cultured arteries were fixed overnight in EMgrade 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, #15713S) then
embedded in paraffin before sectioned at 5µm. Immunohistochemical processing of the
tissues commenced with initial deparaffinization in Histoclear solution (National
Diagnostic, Atlanta, #HS-200) and rehydration in graded concentrations of alcohol in
descending order. The tissue samples were subsequently microwaved in a 6.03-pH citrate
buffer in order to recover antigenicity. Permeabilization of the sections in 0.1% Triton X100 (Sigma Aldrich, St Louis, #T-8787) was done prior to incubation in 1% Bovine
Serum Albumin (Santa Cruz Biotechnology, Santa Cruz, #SC-2323) to ensure blockade
of non-specific interactions.

Confocal Microscopy
Using the 5µm arterial sections generated as previously described under
Fluorescent immunohistochemistry section, double staining of the sections was done
using primary antibodies reactive with 3 different pairs of contractile proteins (SMαA MLCK, SMαA -MLC20 and MLCK-MLC20). Following an overnight primary incubation,
the sections were washed in phosphate buffer solution (PBS) and left to equilibrate with
species matched secondary antibodies labeled with Dylight – 488 (SMαA) and 633
(MLCK) for SMαA -MLCK colocalization, 488 (SMαA) and 633 (MLC20) for SMαA MLC20 colocalization, and 488(MLC20) and 633 (MLCK) for MLCK-MLC20
colocalization. Secondary incubation was done for two hours at room temperature in a
dark room to minimize photo bleaching. Imaging was done with an Olympus FV1000 at
a lateral resolution of 200 nm, optical section width of 700 nm and a numerical aperture
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of 18. Colocalization indices were completed using a non-parametric quadrant analysis as
previously described. Sources and titer ratios of the primary antibodies include: SigmaAldrich, St Louis for monoclonal anti-MLC20 (#M4401) @ 1:300, polyclonal anti-SMαA
(abcam, ab5694) @1:200, monoclonal anti- SMαA (A5228) at 1:200 and Santa Cruz
Biotechnology for polyclonal MYLK (SC-25428) @ 1:50.

Western Blotting
Carotid artery segments of known weights were homogenized using a glass-onglass method in a high urea (8M) extraction buffer containing (in mM) 500 NaCl, 23
Glycine, 20 Tris, 10 EGTA and 10% Glycerol at pH 8.6. Protease inhibitor cocktail
(Sigma-Aldrich, Saint Louis, #M1745) at 5 µl/ml of buffer was also added to the
extraction buffer. After the tissues were grinded in the extraction buffer, the homogenate
samples were centrifuged at 5,000G for 20 min. Protein concentrations were determined
using the Bio-Rad Bradford assay. Post centrifugation, homogenates along with
progressively increasing concentrations of standards used to calibrate target protein
abundance was separated with an SDS-PAGE set-up. Separated proteins were
electrophoretically transferred from the gel matrix onto nitrocellulose membranes at 200
mA current for 1.5 hr in Towbin’s buffer containing 192 mM Glycine, 25 mM Tris, 10%
and 20% Methanol. The transfer process was conducted with ice packs on both sides of
the transfer tank to mitigate the heat generated via electrophoresis. Following transfer
onto nitrocellulose, the membranes were blocked for 1 hr with Tris buffered saline
containing 5% nonfat dry milk (M-TBS) while applying gentle shaking. Afterwards,
membranes were washed in a detergent (0.1% Tween-20) containing MTBS and then
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incubated with primary antibodies for 3 hr using 1:3000 for SMαA, 1:10,000 for MLCK,
1:200 for MLC20 (all three from Sigma Aldrich as stated under “Confocal Microscopy
section” and 1:750 for VEGF-A165 (from Abcam, Cambridge, #AB119). Following
primary incubation, secondary antibody conjugated to Dylight 800 sourced from Pierce
Chemical, Rockford, #46422 was applied to the membranes for 90 min before imaging
was completed via a LI-COR Bioscience Odyssey system.
Tissue homogenization for quantifying VEGF receptors was initiated via a glass
pestle and mortar using an extraction buffer containing (in mM) 500 NaCl, 50 Tris and 5
EDTA at pH 7.4. Six different protease inhibitors including (in µM) 500 AEBSF, 400
Pepstatin-A, 20 Bestatin, 10 E-64, 7.5 Leupeptin and 7 Aprotinin all purchased from
Sigma-Aldrich, Saint Louis, MO were also added to the buffer. A 1:50 tissue extraction
buffer ratio was used. Next, centrifugation of the homogenate was done at 100,000 XG
for 1 hr at 4oC after which the pellet was resuspended into the buffer at a 1:10 ratio with
the addition of (in mM) 150 NaCl, 50 Tris, 10 DTT, 1% Triton X-100, 0.5% Na
Deoxycholate, 0.2% SDS and 10% Glycerol with same concentrations of protease
inhibitors listed above. Following this, the homogenate was ultra-sonicated at 20%
amplitude to shear DNA for 6 times @ 5sec each, centrifuged again at 10,000 XG for 15
min. Collected supernatants were assayed for total protein concentrations via Bradford’s
protein assay. Separation of the proteins was completed using a 5% SDS-PAGE with the
addition of b-mercaptoethanol (BME- 35 mM) in the upper part of the tank with the
buffer. As stated in the above paragraph, standard pooled reference samples were
included in the separation gel lanes. Proteins from the electrophoresis gel were
transferred onto a nitrocellulose membrane using Towbin’s buffer at 350mA for 1.5 hr.
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Towbin’s buffer used here is same as the one described in the previous paragraph but
with the addition of 35 mM of BME, 0.01% SDS and 20% Methanol only. With the
proteins now successfully transferred on membranes, blocking was done with MTBS for
60 min at room temperature while applying gentle shaking. Membranes were
subsequently washed in 0.1% Tween containing MTBS. Incubation with primary
antibodies was done for 3 hrs using dilutions for Flk-1 (Fetal Liver Kinase 1) (SC-504)
and for Flt-1 (Fms-like tyrosine kinase receptors) (SC-316) both purchased from Santa
Cruz using titers of 1:200. Following primary incubation, membranes were washed for 5
mins X 6 before secondary incubation commenced for 90 min. The same secondary
antibody as the one described in the previous paragraph was used. Next, membranes were
washed in TBS only for 5 mins X 6 before the membranes were imaged with a LI-COR
Bioscience’s Odyssey system.

Organ Culture
To determine the effects of VEGF and its receptor antagonists compared to those of
hypoxia, arterial segments from both normoxic and hypoxic sheep were maintained in
Media (Dulbecco’s Modified Eagle Media) containing 70 µg/ml of Gentamycin (Gibco,
Carlsbad, #15750-060), 4 mM glutamine (Sigma Aldrich, St. Louis, #G7513), 3.7 g/l of
Na2HCO3, 2% antibiotic-antimycotic solution (Gibco, CARLSBAD, #15240-096), 1%
non-essential amino acid solution (Sigma Aldrich, St Louis, #M7145), 0.5% amino acid
solution (Sigma Aldrich, St. Louis, #M5550) in a 12-well untreated plate. Incubation was
done in a humidified incubator with 5% CO2 at 37oC. Control arteries were defined as
those kept in Media for an additional 24 hrs after the initial 24hrs while those incubated
in media containing 3 ng/ml of VEGF, 240 nM of Vatalanib and 6.3 nM of Dasatinib
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served to determine the effect of VEGF and VEGF tyrosine kinase receptors. Treatment
groups were defined as those that were kept in media for an initial 24 hr and then an
additional 24 hr in media containing the various drugs.

Data Analysis and Statistics
Each animal sacrificed contributed to segments used in fresh, control, VEGF and
VEGF receptor antagonist treatment groups. Normal distribution of data sets was tested
using the D’Agostino-Pearson analysis whereas contractile stress measurements, wall
thicknesses and stiffness were compared using analysis of variance (ANOVA). Within
ANOVA, homogeneity was verified using a Bartlett’s-Cochran test and statistical power
was at least 0.8. In calculating contractile stresses, a robust computation involving force
generated (g) by graded strains per unit area (length X working wall thickness -µm) was
used.
For western blotting, unknown concentrations of protein of interest were measured
against a standard curve generated from a pooled reference of ovine adult carotid tissues.
Abundances from normoxic and hypoxic groups were compared using 2-way analysis of
variance (ANOVA).
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Results
A total of 10 normoxic and 11 hypoxic sheep were used in this study. The normoxic
sheep contributed 108 arterial segments and the hypoxic ones contributed 91 segments. In
all cases, “n” denotes number of sheep used in each protocol and p<0.05 represents
comparative results of statistical significance. Data here was presented as mean± SEM.

Chronic Hypoxia Alters Arterial Structure and Contractility in Adult
Carotid Arteries
Medial thicknesses averaged 685±62 µm and 846±51 µm in normoxic and hypoxic
arteries respectively (Figure 1, left panel); thus chronic hypoxia significantly increased
medial thickness by 24%. Likewise, stiffness coefficients averaged 5.99±0.40 and
7.36±0.41 in fresh normoxic and hypoxic arteries respectively (Figure 1, middle panel);
chronic hypoxia significantly increased arterial stiffness by 23%. Stretch ratio at peak
myogenic tone averaged 2.42±0.12 and 2.05±0.11 for in normoxic and hypoxic arteries
respectively (Figure 1, right panel); thus chronic hypoxia significantly decreased stretch
ratio to attain peak myogenic tone by 15%. Similarly, peak myogenic tone averaged
71.4±14.6 and 40.8±14.3 in normoxic and hypoxic arteries respectively (Figure 1, right
panel); chronic hypoxia thus decreased peak myogenic tone by 43%.
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Figure 1: Arterial structure and contractility are altered by chronic hypoxia. Arteries
from sheep subjected to hypoxic acclimatization exhibited increased medial thickness
(left panel) and stiffness (middle panel) compared to the normoxic control group. In
contrast, stress strain experiments showed a decreased maximum stretch ratio as well as
peak myogenic tone in arteries from hypoxic sheep compared to normoxic control sheep.
Results are presented as mean ± SEM for n=8 for normoxic arteries and n=11 for hypoxic
arteries. P<0.05 denotes comparative significant differences illustrated by an asterisk (*).
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Chronic Hypoxia Alters Smooth Muscle Contractile Protein
Expression
Chronic hypoxia exerted unique and protein specific changes in abundance of
smooth muscle contractile proteins. For SMαA, quantification via Western
immunoblotting showed a significant difference in abundance in normoxic (1.42±0.08)
compared to hypoxic (2.19±0.2) arteries. Hypoxia resulted in a 54% in SMαA abundance.
For MLCK, abundances in normoxic and hypoxic arteries averaged 1.34±0.14 and
0.71±0.31 respectively; hypoxia produced a 47% decrease in MLCK abundance. For
MLC20, abundances averaged 0.65±0.09 and 1.10±0.18 in normoxic and hypoxic arteries
respectively; hypoxia resulted in a 69% increase in MLC20 abundance (Figure 2).
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Figure 2: Chronic Hypoxia differentially alters smooth muscle contractile protein
expression. Quantification of smooth muscle contractile proteins via Western
immunoblotting assays revealed a significantly higher level of SMαA and MLC20 in
hypoxic arteries compared to normoxic control arteries. In sharp contrast, MLCK
abundance decreased with chronic hypoxia compared to normoxic values. These results
suggest a highly protein specific alteration effect of hypoxia in these ovine carotid
arteries. Results here are presented as mean ± SEM for n=7 for all normoxic groups and
n=6 for all hypoxic groups. Comparative significant differences denoted by asterisk (*)
denotes p<0.05.
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Effects of Chronic Hypoxia on Contractile Protein Colocalization
Coefficients of colocalization between MLCK and SMαA were similar in both
normoxic (2.43±0.78) and hypoxic (2.08±0.84) (Figure 3, left panel) arteries. For
MLC20- SMαA, colocalization coefficients averaged 3.09±1.63 and 24.83±6.66 for
normoxic and hypoxic arteries respectively (Figure 3, middle panel); hypoxia produced
a 704% increase in colocalization between MLC20 and SMαA. Similarly, for MLCKMLC20 colocalization, coefficients averaged 7.71±4.36 and 33.56±13.44 for normoxic
and hypoxic arteries respectively (Figure 3, right panel); hypoxia produced a 335%
increase in colocalization between MLCK and MLC20.
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Figure 3: Effects of chronic hypoxia on contractile protein colocalization. Interactions
between smooth muscle contractile proteins assayed through confocal colocalization
microscopy revealed a 704% increase in MLC20-SMαA colocalization and a 335%
increase in MLCK- MLC20 colocalization in hypoxic compared to normoxic arteries. For
MLCK-SMαA colocalization however, coefficients were similar in both normoxic and
hypoxic arteries. Results are presented as mean ± SEM for n≥5 for all experimental
groups. Comparative significant differences denoted by an asterisk (*) represents p<0.05.
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Effects of Chronic Hypoxia on VEGF and VEGF Receptor Expression
Following 110 days of hypoxic acclimatization, expression of VEGF (1.44±0.23)
was not significantly different from normoxic control value (1.39±0.17), suggesting that
chronic hypoxia had no appreciable effect on VEGF abundance (Figure 4). In contrast,
VEGF receptors (flk-1 and flt-1) expression potently increased with chronic hypoxia. For
flk-1, abundances increased from 5.87±0.99 in normoxic arteries to 15.01±1.87 in
hypoxic arteries. Also for flt-1, abundances increased from 0.87±0.17 in normoxic
arteries to 1.80±0.38 in hypoxic arteries (Figure 5).
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Figure 4: Chronic hypoxia does not significantly increase VEGF expression. Western
blot quantification of endogenous VEGF levels in arteries harvested from sheep
acclimatized to chronic hypoxia for 110 days yielded values similar to those obtained in
arteries harvested from normoxic control sheep. This result suggests that initial increases
in VEGF levels (well documented) were not sustained chronically. Results are presented
as mean ± SEM for n=7 and 6 for normoxic and hypoxic arteries respectively.
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Figure 5: Chronic hypoxia upregulates VEGF receptors. Whereas Western blot
quantification of VEGF levels were not altered by chronic hypoxia, abundances of VEGF
tyrosine kinase receptors were significantly increased by chronic hypoxia. VEGF
receptor 1 – Flt-1 level was increased by 107% and VEGF receptor 2- Flk-1 was
increased by 156% in hypoxic arteries. Results are presented as mean ± SEM for n=6 for
all experimental groups. Comparative significant differences denoted by an asterisk (*)
imply p<0.05 via ANOVA.
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VEGF-induced Changes in Contractile Protein Interactions are
Maintained Through VEGF Receptor Upregulation
To test the upregulation of VEGF tyrosine kinase receptors as a possible
mechanism for VEGF alteration of contractile protein interactions, MLC20- SMαA
colocalization was used as a reporter assay. Whereas VEGF (3 ng/ml) in culture produced
a 377% increase in MLC20- SMαA colocalization, cocultures with VEGF receptor
antagonists’ vatalinib (240 nM) and dasatinib (6.3 nM) produced a complete blockade of
this effect (Figure 6).
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Figure 6: Chronic hypoxia alters contractile protein colocalization through upregulation
of VEGF receptors. VEGF in culture produced significant increases (377%) in
colocalization between MLC20 and SMαA. Co-cultures with VEGF receptor antagonists,
Vatalinib (240 nM) and Dasatinib (6.3 nM), completely blocked the potent effect of
VEGF on these contractile proteins. These results suggest that VEGF induced changes in
interactions between the contractile proteins are mediated through the receptors. Results
are presented as mean ± SEM for n = 5 in all experimental groups. Comparative
significant differences denoted by an asterisk (*) imply p<0.05 via ANOVA.
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Effect of VEGF in Culture on Contractile Protein Abundances
Low dose (3 ng/ml) VEGF in culture had no significant effect on SMαA
(1.38±0.09) MLCK (0.09±0.04) or MLC20 abundances (0.42±0.08) in normoxic arteries.
However in hypoxic arteries, VEGF produced 51%, 83% and 161% increases in SMαA,
MLCK and MLC20 abundances; thus replicating effects of hypoxia on SMαA and MLC20
but not MLCK in culture.

93

Figure 7: VEGF replicates hypoxic effects on SMαA and MLC20 expression. Organ
culture of endothelium-denuded common carotid arteries with low dose VEGF (3 ng/ml)
resulted in significant increases in SMαA (left panel) and MLC20 (right panel) abundance.
For MLCK, levels in VEGF treated arteries were similar to levels in normoxic control
arteries (middle panel). VEGF thus replicates effects of chronic hypoxia in a highly
protein specific manner, suggesting that VEGF might be mediating hypoxic changes in
contractile protein expression in ovine carotid smooth muscle cells. Data are presented as
mean ± SEM for n=7 and 6 for normoxic and hypoxic arteries respectively. Comparative
significant differences denoted by an asterisk (*) imply p<0.05 via ANOVA.
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Effect of VEGF on Contractile Protein Interactions
Again, VEGF produced distinct effects on contractile protein colocalization. For
MLCK- SMαA colocalization, coefficients increased from 3.85±0.93 in control arteries to
7.99±0.86 in VEGF treated arteries; VEGF produced a 108% increase in colocalization
between the two contractile proteins. Similarly, for MLC20- SMαA colocalization,
coefficients increased from 1.00±0.45 in control arteries to 4.77±3.01 in VEGF treated
arteries; VEGF produced a 377% in colocalization between the two contractile proteins.
For MLCK-MLC20 colocalization, coefficients were similar for control and VEGF treated
arteries; VEGF had no effect on colocalization between the two contractile proteins.
VEGF produced similar effects as hypoxia only for MLC20- SMαA colocalization.
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Figure 8: VEGF replicates hypoxic effects on MLCK-SMαA and MLC20-SMαA
colocalization. Organ culture of normoxic arteries with 3 ng/ml of VEGF increased
colocalization of MLCK with SMαA and MLC20 with SMαA. For MLCKMLC20colocalization, VEGF had no significant effect on their colocalization coefficient.
These results show that VEGF replicates hypoxic effects on MLC20-SMαA
colocalization, suggesting that VEGF mediates hypoxic alteration of contractile protein
interaction in a highly protein specific manner. Data here are presented as mean ± SEM
for n ≥ 5 for all experimental groups. Comparative significant differences denoted by an
asterisk (*) imply p<0.05 via ANOVA.
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Discussion
This study offers four main original findings. First, long-term hypoxia (110 days at
altitude of 3820 m) increased medial wall thickness and overall stiffness but decreased
spontaneous myogenic tone. Second, long-term hypoxia had no effect on tissue VEGF
levels but increased abundances of both the R1 and R2 subtypes of VEGF receptors.
Third, both long-term hypoxia and organ culture with VEGF increased abundances of
SMαA and MLC20, but had opposite effects on MLCK abundance. Fourth, VEGF in

organ culture replicated effects of long-term hypoxia on contractile protein colocalization
of MLC20 with SMαA, but not for MLCK with SMαA nor for MLCK with MLC20,
suggesting that factors other the VEGF contribute to hypoxic vascular remodeling.
Overall, the current study demonstrates that hypoxic vascular remodeling involves a
long-term up-regulation of VEGF receptors that can explain some, but not all, of the
effects of chronic hypoxia on contractile protein abundance, organization, and function.

Long-term Hypoxia Alters Arterial Structure and Contractility
Chronic exposure to hypoxia typically promotes increased wall thickness in most
arteries (30, 46) due largely to expansion of the adventitial layer (14). Some studies have
also found, however, that resident cells in the medial layer can undergo hypertrophy (41,
45) and hyperplasia (7) upon chronic exposure to hypoxia. This medial hyperplasia, in
turn, can result from hypoxia induced de-differentiation of fully contractile smooth
muscle cells into synthetic cells with potent abilities to proliferate, migrate, and secrete
extracellular matrix proteins (6). Recent findings further suggest that adventitial
fibroblasts and smooth muscle progenitor cells can invade the medial layer and
differentiate into myofibroblasts (32), adding further to hypoxic increases in medial
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thickness. The current findings (Figure 1) reinforce previous reports that chronic hypoxia
can increase medial thickness, and further demonstrate that this response includes an
increase in passive arterial stiffness. This increase in stiffness, in turn, suggests either an
increase in the collagen-to-elastin ratio, or an increase in collagen cross-linking (17, 58).
Accompanying these increases in thickness and stiffness, the data also revealed that
chronic hypoxia depressed myogenic reactivity (Figure 1). Because stiffness was
increased, these results together suggest that hypoxia decreased either the efficiency of
mechanotransduction, the strength of its coupling to the myogenic response, or overall
contractile capacity (2, 15, 31). In light of previous results suggesting that hypoxia can
promote the transformation of smooth muscle phenotype from a contractile to a more
synthetic phenotype (6) and thereby decrease contractility (24), our next series of
experiments examined the effects of hypoxia on the abundance and organization of three
key contractile proteins.

Chronic Hypoxia Differentially Modulates Contractile Protein
Abundances
Smooth muscle α-actin (SMαA) is the most abundant contractile protein in
vascular smooth muscle and is the main component of the thin filament cytoskeleton
essential for force production via interactions with activated myosin cross-bridges (27,
61). Immunoblot quantification demonstrated a significant increase in SMαA abundance
in response to chronic hypoxia (Figure 2). This effect could be explained by the presence
of a hypoxia responsive element (HRE) in the SMαA promoter, but evidence supporting
this hypothesis has yet to be reported. Another possibility is that the translation efficiency
for SMαA could be increased by hypoxia. Although a variety of interesting evidence

98

suggests that miRNAs can significantly modulate actin abundance and assembly (63),
evidence that chronic hypoxia can stimulate the actions of any of these miRNAs is not
available in the literature. Given that SMαA is one of the first contractile proteins
expressed in newly differentiated smooth muscle (44), hypoxic increases in SMαA might
also reflect increased smooth muscle cell proliferation (11, 58). Aside from the
mechanism through which chronic hypoxia increased SMαA abundance, it is clear that
the direction of this change cannot explain the parallel hypoxic inhibition of myogenic
contractility (Figure 1).
Regulatory myosin light chain, also known as 20 kDa myosin light chain (MLC20),
is another critically important contractile protein in smooth muscle; phosphorylation of
its serine 19 is prerequisite for contraction (60). As observed for SMαA, chronic
exposure to hypoxia significantly increased the abundance of MLC20, again suggesting
possible hypoxic enhancement of the transcription or translation of MLC20 mRNA.
Evidence supporting any influence of hypoxia on either the transcription or translation of
mRNA for MLC20, however, has not been reported. Alternatively, hypoxic increases in
smooth muscle proliferation (11, 58) could also explain increased abundance of MLC20.
As for hypoxic increases in SMαA abundance, these increase in MLC20 abundance
appear to be generally inconsistent with the observed hypoxic depression of myogenic
contractility (Figure 1), unless these increases are occurring more in non-contractile
synthetic smooth muscle than in fully differentiated contractile smooth muscle (52).
Myosin Light Chain Kinase (MLCK) is the dedicated kinase that phosphorylates
serine 19 of MLC20, and thus initiates smooth muscle contraction (23). In contrast to the
patterns observed for SMαA and MLC20, acclimatization to chronic hypoxia decreased

99

MLCK abundance by 47% (Figure 2). In turn, this result suggests a possible hypoxic
inhibition of either transcription or translation of mRNA for MLCK, but as for SMαA
and MLC20, the published literature provides no support for such effects of hypoxia in
smooth muscle. Another possibility is that hypoxia promotes the degradation and
turnover of MLCK, but here too evidence of rapid turnover of MLCK has been offered
by in vitro organ culture studies (9), but not by studies of vascular effects of long-term
hypoxia. As for the effects of chronic hypoxia on SMαA and MLC20, hypoxia-induced
shifts in smooth muscle phenotype may also help explain the marked decrease in MLCK
abundance observed in hypoxic arteries, particularly if MLCK is one of the last
contractile proteins to be expressed during contractile differentiation (56). Although the
mechanisms that mediate the protein-specific effects of chronic hypoxia on abundances
of SMαA, MLC20, and MLCK remain unclear, the present results strongly suggest that
the effects of chronic hypoxia on myogenic contractility can be explained, at least in part,
by decreased abundance of MLCK.

Chronic Hypoxia Differentially Modulates Contractile Protein
Organization
Smooth muscle contraction involves rapid and efficient interactions among multiple
contractile proteins whose distribution and organization, as well as their abundances,
powerfully influence contractile force (60). Correspondingly, under some conditions
phosphorylated MLC20 can be uncoupled from force generation, even though all essential
contractile proteins are present at appropriate abundances (37, 38). Such observations
support the hypothesis that the organization of contractile proteins within smooth muscle
is an important determinant of contractility that is physiologically regulated, particularly
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during differentiation and functional maturation (64). To explore the hypothesis that
chronic hypoxia could modulate contractility through changes in contractile protein
organization, the experimental approach focused on the colocalization of several pairs of
contractile proteins.
Consistent with the effects of chronic hypoxia on the abundances of both SMαA and
MLC20, chronic hypoxia increased the fraction of MLC20 colocalized with SMαA
(Figure 3). In contrast, chronic hypoxia had no effect on the fraction of MLCK
colocalized with SMαA despite the finding that hypoxia dramatically reduced MLCK
abundance (Figure 2). More importantly, the fraction of MLCK bound to MLC20 was
increased by adaptation to chronic hypoxia. These latter findings suggest that the MLCK
lost during adaptation to chronic hypoxia came primarily from the fraction not
colocalized with either SMαA or MLC20.This interpretation is consistent with the
hypothesis that MLCK serves important non-kinase and possible structural functions
within smooth muscle (40, 62) that can be sacrificed during adaptation to chronic
hypoxia. Conversely, the data further suggest that contractility is diminished but
preserved in hypoxic arteries through increased colocalization of the remaining MLCK
with MLC20. Taken together, these results emphasize that the organization of contractile
proteins may be more important than their abundance for generating contractile force.

Effects of Long-term Hypoxia on VEGF and VEGF Receptor Levels
To explore the mechanisms mediating hypoxic changes in vascular structure and
function, our experimental approach examined the involvement of VEGF, a welldocumented mediator of hypoxic angiogenesis (22, 59) that can influence the abundances
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and organization of contractile proteins in both normoxic (9) and hypoxic (24) arteries.
Consistent with previous reports that chronic hypoxia transiently increases VEGF (1, 12),
chronic hypoxia of 110 days duration did not significantly change tissue VEGF levels
(Figure 4).
Conversely, chronic hypoxia did significantly elevate the abundances of both the Flk-1
and Flt-1 subtypes of VEGF receptors in arterial tissue (Figure 5). Together, these
findings support the hypothesis that hypoxic remodeling of large adult arteries is
mediated in the short term (<21 days) through increases in VEGF levels, and in the long
term (>28 days) through increases in VEGF receptor levels, as previously suggested in
fetal arteries (1).

VEGF Receptors Mediate Arterial Remodeling
To confirm that VEGF receptors can mediate VEGF-induced modulation of
contractile protein organization, a separate series of organ culture experiments quantified
the effects of exposure to VEGF, in the presence and absence of VEGF receptor
antagonists, on contractile protein colocalization. Given that colocalization between
MLC20 and SMαA was increased by chronic hypoxia (Figure 3), we used this pair of
proteins to monitor the effects of a low, physiological concentration of VEGF (3 ng/ml),
as previously reported (1). Consistent with our findings in fetal carotid arteries (1),
cocultures of VEGF with optimal doses of vatalinib (240 nm) alone or with dasatinib (6.3
nm) completely inhibited VEGF effects on MLC20 – SMαA colocalization (Figure 6).
These results support the hypothesis that contributions of VEGF to hypoxic vascular
remodeling occur via VEGF receptors 1 and 2 in ovine adult carotid arteries. To further
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elucidate mechanisms through which VEGF contributes to hypoxic vascular remodeling,
we conducted a series of western immonoblotting and colocalization studies on VEGF
treated arterial segments.

VEGF Differentially Modulates Contractile Protein Abundances and
Colocalization
Quantification of the SMαA via immunoblot analysis showed that similar to
hypoxia, VEGF in culture produced a significant increase in SMαA abundance (Figure
7). This result suggests that VEGF might be contributing to the process of hypoxic
vascular remodeling through modulation of smooth muscle cellular proliferation that
results in SMαA upregulation (11, 58). Comparison of this result to our earlier work
which showed that VEGF in culture upregulated SMαA abundance in fetal arteries
suggests that post natal maturation does not alter smooth muscle cell reactivity to VEGF
in terms of SMαA abundance. This might be related to the fact that SMαA is the most
abundance marker contractile protein in smooth muscle cells regardless of age group (27,
52).
Again for MLC20, similar to hypoxic effect on fresh arteries, VEGF in organ culture
produced a significant increase in MLC20 abundance (Figure 7). This result once again
suggests that VEGF contributes to hypoxic vascular remodeling through upregulation of
MLC20, which though is inconsistent with decreased myogenic contractility observed, but
nonetheless is crucial for the induction and maintenance of contractility (60).
For MLCK, in contrast to the pattern observed with hypoxic effect on fresh arteries,
VEGF in culture had no significant on MLCK abundance (Figure 7). This suggests that
contribution of VEGF to hypoxic vascular remodeling as it relates to contractile protein
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abundance is unique and highly protein specific (9). Also this result suggests that some
fundamental factors, yet to be elucidated, promote postnatal maturation alteration of
cellular reactivity to VEGF. Our previous finding in fetal sheep (1), which showed that
VEGF replicated hypoxic effects on MLCK abundance, supports this hypothesis.
Having shown the differential effects of VEGF on contractile protein abundances,
we tested the hypothesis that VEGF contributes to hypoxic vascular remodeling through
alteration of contractile protein interactions. Whereas hypoxia had no effect on MLCK –
SMαA colocalization, the first set of experiments showed that VEGF produced
significant increases in colocalization between the two proteins (Figure 8).
Also for MLCK – MLC20 colocalization, whereas hypoxia produced significant
increases in colocalization between them, VEGF in culture had no effect on their
colocalization (Figure 8). Taken together, VEGF neither replicated hypoxic effects on
MLCK abundance nor colocalization of other contractile proteins with MLCK. These
results support our earlier hypothesis that certain fundamental factors alter reactivity of
smooth muscle cells to VEGF postnatally with consequent alteration of MLCK
production. Perhaps these same factors are the ones responsible for the precipitous drop
in MLCK abundance secondary to long-term hypoxic acclimatization (1, 9). A striking
decrease in MLCK abundance which has been shown to trigger apoptotis (18) and
observed here with hypoxic acclimatization might profer leads to those factors which
might be involved with altered MLCK signaling postnatally.
For MLC20 – SMαA colocalization, VEGF in culture replicated hypoxic effects on
fresh arteries (Figure 8). This might be related to increased abundances in both MLC20
and SMαA abundances observed with both hypoxia and VEGF in culture. Together, this
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result suggests that at least in part, VEGF contributes to hypoxic vascular remodeling
through differential and protein specific alterations in contractile protein abundance and
interactions.

Overview
This study focuses on elucidating mechanisms involved with hypoxic vascular
remodeling through a direct effect on arterial smooth muscle cells. This process is a
dynamic one necessary for living cells to adapt and contend with prevailing internal and
external stimuli (25, 46). In this study, we explored a well-established mediator of
angiogenesis (VEGF), which has recently been suggested as a pivotal factor in vascular
remodeling. Hypoxic increases in HIF-1a result in modulated angiogenic transcription of
VEGF as early as 24 hr of hypoxic exposure but falls back to basal levels by day 7 – 21
(28). Here we tested the role of endogenous VEGF in vascular remodeling after 110 days
of hypoxic acclimatization (Figure 9, arrow 1). VEGF binds to its tyrosine kinase
receptors 1 (Flt-1) and 2 (Flk-1) present on smooth muscle cells (Figure 9, arrow 2),
ultimately leading to processes of angiogenesis (22), arterial structural changes and
altered contractility (Figure 9, arrow 4). Parallel studies were done to quantify
abundances of VEGF receptors after long-term hypoxic acclimatization (Figure 9, arrow
3) owing to their important role in VEGF signaling.
Consistent with literature, hypoxia resulted in increased arterial medial thickness
and stiffness but decreased spontaneous myogenic reactivity (Figure 1). Also, hypoxic
acclimatization produced significant increases in SMαA and MLC20 but markedly
decreased MLCK abundances (Figure 2). MLCK decreases correlated the most with
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decreased contractile reactivity observed. Despite this decrease in MLCK, colocalization
studies showed that its colocalization with MLC20 was significantly increased after
hypoxic acclimatization. Similarly, MLC20 – SMαA colocalization increased with
hypoxia but no changes occurred in MLCK – SMαA colocalization (Figure 3). To test
the hypothesis that VEGF contributes to these hypoxic changes in structure and function
we quantified endogenous VEGF and VEGF receptor levels. Whereas after 110 days of
hypoxia, VEGF levels were not different from basal levels (Figure 4), both VEGF
receptors significantly increased (Figure 5), suggesting that remodeling effects of
hypoxia are maintained through long-term upregulation of VEGF receptors (Figure 6).
Also VEGF was shown to replicate hypoxic increases in SMαA and MLC20 in culture but
not MLCK abundances (Figure 7). Similarly, MLCK colocalizations with other
contractile proteins in VEGF treated segments were dissimilar to those observed with
hypoxia. In contrast, VEGF replicated hypoxic increases in MLC20 – SMαA
colocalization (Figure 8). Together these results suggest that trends of VEGF
involvement in hypoxic vascular remodeling change with postnatal maturation. Also
MLCK decreases observed with hypoxia and shown to orchestrate apoptotic processes
and factors probably alter cellular synthesis and turnover of MLCK, hence affects its
colocalization with other contractile proteins. Finally, these results largely support the
hypothesis that VEGF contributes to hypoxic vascular remodeling through differential
and protein specific changes in contractile protein abundances and interactions.
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Figure 9. This schematic illustrates the steps we took in testing the hypothesis that
VEGF contributes to hypoxic vascular remodeling in adult ovine carotid arteries through
alteration of contractile protein abundance, organization and function. First, we tested the
propensity of long-time time hypoxia to directly increase endogenous VEGF (Arrow 1)
and also VEGF receptors 1 (Flt-1) and 2 (Flk-1) (Arrow 3). Also we tested the possibility
of VEGF signaling through its receptors (Arrow 2) to effect changes in arterial structure
(arterial wall thickness and stiffness, contractile protein abundances) and contractility
(contractile protein interaction and myogenic tone) (Arrow 4). Using this experimental
layout, we proposed to explore involvement of VEGF in the non-angiogenic role of
remodeling.
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Abstract
In addition to its role in angiogenesis, VEGF may also contribute to arterial
remodeling, possibly through activation of VEGF receptors on sympathetic nerves
leading to altered trophic input to the arterial wall. To test this hypothesis normoxic and
chronically hypoxic fetal sheep (110 days at 3820m) underwent unilateral superior
cervical sympathectomy (SANX) at 124d gestation, and then were harvested at 138d
(term). In middle cerebral arteries (MCA), hypoxia increased dopamine beta hydroxylase
368% and SANX ablated this increase. Hypoxia also decreased by 34% colocalization
between Non-Muscle Myosin Heavy Chain (SMemb) and smooth muscle α-actin (AA)
indicating increased contractile differentiation; SANX increased this colocalization
106%. Conversely, hypoxia increased by 125% SM2-MHC colocalization with AA,
again indicating increased differentiation; SANX decreased this colocalization by 81%.
Organ culture of MCA with NE increased colocalization of SM2-MHC with AA by
150% in SANX arteries; the effects of NE were blocked by prazosin. These results
suggest that hypoxic increases in VEGF alter sympathetic release of NE and/or other
factors that transform the contractile phenotype of cerebrovascular smooth muscle. This
transformation appears to be a central feature of hypoxic cerebrovascular remodeling in
the fetus.

Key Words
Hypoxia, Sympathetic, Perivascular nerve, Myosin Light Chain Kinase,
Regulatory Myosin Light Chain, Smooth Muscle, VEGF
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Introduction
Animal species are endowed with the intrinsic ability to maintain tissue perfusion
and oxygenation, which is critical to their survival (31). During periods of reduced
oxygen tension i.e. hypoxia, HIF-1α via its hypoxia response element results in
transcription of angiogenic genes that produce cytokines which aid angiogenesis (40).
One of such cytokines is Vascular Endothelial Growth Factor (VEGF), which has been
extensively shown to mediate angiogenesis and vasculogenesis via its tyrosine kinase
receptors (13, 19).
As the name suggests, VEGF from endothelial cells has been shown to produce
autocrine effects on endothelial cells (27, 30, 44) as well as paracrine remodeling effects
on the medial and adventitial layers (39). Of recent, some studies have suggested a direct
remodeling effect of VEGF on the vascular medial layer via VEGF receptors present on
the resident smooth muscle cells (1, 25, 47, 51).
Both autocrine and paracrine effects of VEGF have been suggested to be signaled
through VEGF receptors 1 and 2 present on the vessel wall (37). Downstream, VEGF
mediates genomic changes producing alterations in contractile protein abundances and
organization (1, 6). Some studies have also suggested a phenotypic switch in myosin
isoforms as a possible mechanism for VEGF mediated hypoxic vascular remodeling in
ovine carotid arteries (21). A recent line of studies has shown the presence of VEGF
receptors on sympathetic nerves and also the involvement of VEGF in differentiation and
growth of nerve fibers (29, 41). In like manner, sympathetic nerves have been shown to
modulate differentiation, growth and functioning of the intimal layer of blood vessels
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(10). This important finding suggests the possibility of paracrine effects of VEGF on the
vessel wall via VEGF receptors expressed on resident nerve cells.
With these background findings in mind, this current study explores the hypothesis
that hypoxic increases in VEGF contributes to arterial remodeling in ovine cerebral
arteries via sympathetic perivascular nerve alteration of smooth muscle cell phenotype.
Using a well established long-term hypoxia model in sheep, we compared the effects of
animals acclimatized to altitude and their normoxic controls kept at sea level for patterns
of arterial remodeling (23, 28). To test the hypothesis that sympathetic perivascular
nerves mediate remodeling effects of hypoxia, we conducted unilateral superior cervical
sympathectomy (2) on time-dated normoxic and hypoxic fetuses at 124 day gestation and
harvesting both ipsilateral and contralateral middle cerebral arteries at term for various
biochemical analyses. To determine sympathetic perivascular nerve alteration of smooth
muscle cell phenotype, we quantified abundances of known markers for both synthetic
and contractile smooth muscle cell phenotype i.e. non-muscle isoform of heavy chain
myosin (SMemb), heavy chain myosin-1 (SM-1) and heavy chain myosin-2 (SM2).
Taken together, this study provides some mechanistic explanations for involvement
of sympathetic perivascular nerve in hypoxic vascular remodeling and thus expands the
current knowledge on reactivity of the vasculature to hypoxia, which is involved in a
great percentage of clinical pathologies.
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Materials and Methods
Techniques, protocols and procedures employed in these studies received approval
from the Animal Research Committee of Loma Linda University and were in line with
the policies and code of practices outlined in the National Institutes of Health Guide for
the Care and Use of Laboratory Animals. Procedures related to tissue harvesting,
preparation and animal surgery have been previously described in detail (1, 6).

Tissue Harvest and Preparation
Experiments conducted in this study made use of middle cerebral arteries harvested
from term fetal (139 – 142 days gestation) sheep harvested and prepared using very strict
sterile procedures. Contractility, electrical nerve stimulation and immunohistochemical
experiments involved use of arteries from two main groups of animals in terms of
percentage oxygen they were exposed to; first, normoxic arteries generated from animals
maintained at sea level and second, hypoxic arteries generated from animals chronically
acclimatized at altitude of 3820m above sea level for the final 110 days of gestation. The
chronic hypoxia model used in this study exposes fetal sheep to arterial oxygen tensions
(PaO2) of 19±1 within the hypoxic period (23). Experiments involving use of denervated
arteries begins with performing a unilateral superior cervical ganglionectomy on fetuses
at 125 – 128 days gestation through a head exteriorization via a midline incision while
still attached to the pregnant ewe. After removal of the ganglion, the surgical wound is
repaired and fetus is reduced back into the uterine cavity and left for another two weeks
before the fetus is harvested.

121

The process of harvesting the fetus begins with anesthetization of pregnant ewes
with 30mg/kg pentobarbital, intubated and maintained on 1.5 – 2.0% halothane gas. With
the use of midline vertical incision, fetuses are subsequently exteriorized and rapidly
exsanguinated by removal of the heart. The pregnant ewes from which the fetuses are
harvested are subsequently sacrificed using 100mg/kg eutosol administered IV.
Harvested arteries are placed in sterile HEPES buffer solution made up of (in mM) 122.1
NaCl, 25 HEPES, 5.16 KCl, 2.4 MgSO4, 11.1 dextrose, 1.6 CaCl2 and 50 µM EDTA.
Arteries are carefully cleaned of loose connective tissues, blood and subsequently cut into
3mm lengths of coronal slices then distributed into various experimental groups. Precise
arterial segment length measurements were done using an Olympus U-PMTVC Optical
microscope mounted with a Scion Visicapture Twain 1394 Camera for image capture
with ImagePro Software (v6.0, Media Cybernetics) for analysis.

Electrical Transmural Stimulation
5mm segments of cleaned MCA from both normoxic and hypoxic animals were
mounted on tungsten wires between force transducers and micrometers that provide
precise diameter increases, while immersed in Na+ Krebs solution (pH7.4) containing (in
mM): 122 NaCl, 25.6 NaHCO3, 5.17 KCl, 2.56 dextrose, 2.49 MgSO4, 1.60 CaCl2, 0.114
ascorbic acid and 0.027 EGTA. The solution was continuously bubbled with 95% O2 and
5% CO2 at 38oC. Successive increases in stretch were applied to the tissues until the
optimum resting tension was obtained for each segment. Following this, the segments
were left to equilibrate for 30 minutes before maximum K+ induced active tone was
measured by adding K+ Krebs buffer which consists of (in mM) 122 KCl, 11.1 dextrose,
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5.16 NaCl, 2.50 MgSO4, 2.15 NaHCO3, 1.60 CaCl2, 0.114 ascorbic acid, and 0.027
EDTA. Arterial responses to electrical stimulation frequency were characterized by
delivering supramaximal voltage and constant current to the tissues through two platinum
field electrodes placed parallel and on either side of the arterial segment. These trains of
square-wave pulses were of 0.3 ms durations. Each segment was stimulated at each of
five frequencies: 8, 1, 2, 4, 8 and 16 Hz for 2.5 minutes, with a 5 minute rest period
between successive stimulations.

Western Immunoblotting
Known weights of frozen arterial tissues were lysed via glass-on-glass in 8M Urea,
(in mM) 10 EGTA, 20 Tris, 23 Glycine, 500 NaCl and 10% Glycerol at pH 8.6 with
addition of a protease inhibitor cocktail at 5 µl/ml of buffer (Sigma-Aldrich, Saint Louis,
#M1745). Homogenates were centrifuged at 5,000G for 20 minutes after which protein
concentration of the supernatants were determined using the Bio-Rad Bradford assay.
Total cell lysate was analyzed by SDS-PAGE together with increasing concentrations of
standards used to calibrate target abundance. Tissues for the standards were harvested
from pooled fetal ovine middle cerebral arteries. Separated proteins from SDS-PAGE
were transferred onto nitrocellulose membranes at 200 mA for 90 minutes in Towbin’s
buffer (in mM) 25 Tris, 192 Glycine and 10% Methanol) on ice. Membranes were
blocked with 5% milk in Tris buffered saline at pH 7.5 (M-TBS) for 1 hr at room
temperature using continuous gentle shaking. After the initial blocking, subsequent
washes and incubations were done in M-TBS containing 0.1% Tween-20. Incubations
with primary antibody were performed for 3 hours using anti-Dopa Beta Hydroxylase
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antibody (1:500) purchased from Abcam (Cambridge, #AB 43868). Visualization was
done after 90 minutes of secondary incubation with a secondary antibody (1:5000)
conjugated to Dylight 800 (Pierce Chemical, Rockford, #46422). Imaging was done on a
LI-COR Bioscience Odyssey system.

Fluorescent Immunohistochemistry
Posterior communicating artery segments were embedded in Tissue-Tek OCT
media (#14-373-65, Fisher Scientific) on dry ice then sectioned using a Leica CM3050S
cryostat at 10µm thick. Sections were dried onto Superfrost Plus Gold slides (#22-035813, Fisher Scientific) at 37oC for 2hr followed by fixation using -20oC acetone for
10minutes. After Phosphate buffered saline pH 7.4 (PBS) rinses, sections were incubated
with 1% bovine serum albumin (BSA), 5% normal goat serum (NGS) and 0.2% Triton X100 in PBS using CoverWell incubation chambers (#247001, Research Products
International) for 1 hr. All incubations were performed with gentle vibrations achieved
on a stirrer plate (Jacobsen-K.X and Staines-WA Journal of Neuroscience Methods 137
(2004) 71-77). Sections were incubated with a rabbit polyclonal antibody against
Dopamine β-Hydroxylase (ab43868, Abcam) at 1:1000 in 1% BSA, 2% NGS and 0.1%
Triton X-100 in PBS overnight at 4oC. Sections were washed in PBS + 0.1% Tween-20
then incubated 2hrs with a goat anti-rabbit IgG conjugated with Dylight 488 (#35553,
Pierce Chemical) at room temperature. Following washing, sections were mounted with
SlowFade Gold antifade mounting media (S36937, Invitrogen) and coverslipped. Images
were obtained using a Zeiss Axio Imager A1 with Spot software (Ver. 4.6.4.5, Diagnostic
Instruments).
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Wall thickness and Stiffness
Using ImagePro software, immunohistochemically stain slides of tissue coronal
segments were used in determining medial wall thicknesses of arteries from both
normoxic and hypoxic animals. Stiffness coefficients were calculated from contractility
experiments that made use of 3mm cut arterial segments mounted on tungsten wires
between isometric force transducers and micrometers used for precise positioning. Initial
tissue equilibration was conducted for one hour in calcium replete Na+ Krebs buffer
(pH7.4). The equilibration solution was continuously bubbled with 95% O2 with 5% CO2
at normal ovine core temperature of 38oC. Following equilibration, unstressed artery
diameters (D0) were measured at a passive tension of 0.03 g. Working diameters (D)
needed to attain stresses of (in g) 0.3, 0.6, 0.9, 1.2, 1.5 were also calculated Stiffness
coefficient were determined after elimination of the active component of tone by freezing
and equilibrating the tissues in EGTA solution. Stiffness calculations were completed by
normalizing stress values obtained to gravity, arterial length and thickness.

Confocal Microscopy
Segments of MCA were fixed overnight in 4% neutral buffered EM-grade
formaldehyde (Electron Microscopy Sciences, Hatfield, #15713S), paraffin embedded
and sectioned at 5µm. Following deparaffinization in histoclear solution (National
Diagnostic, Atlanta, #HS-200), rehydration in successive dilute concentrations of alcohol,
antigen retrieval in citrate buffer (pH 6.03) and permeabilization in 0.1% Triton X-100
(Sigma Aldrich, St Louis, #T-8787), the sections were incubated in 1% bovine serum
albumin (Santa Cruz Biotechnology, Santa Cruz, #SC-2323) to block non-specific
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binding. Next, the artery sections were double-stained with monoclonal anti- SMαA
(Sigma-Aldrich, St Louis, #M4401) @ 1:100 with polyclonal anti-human SMEMB
(Santa Cruz Biotechnology, Santa Cruz, SC-25428) @ 1:500 or monoclonal anti-SM1 @
1:3000 or monoclonal anti-SM2 @1:400 overnight @ 4oC. The following day, the
sections were washed in PBS and equilibrated in a dark room with secondary antibodies
labeled with Dylight- 488 (SMαA) and 633 (SMemb, SM1 or SM2) for two hours at
room temperature. Imaging of the sections was done using an Olympus FV1000 at an
optical section thickness of 1µm, a lateral resolution of 2 nm and a numerical aperture of
18. Extent of colocalization between the two markers was determined using a nonparametric quadrant analysis, which calculates the fraction of total pixels in the upper
half of the intensity range for both markers relative to the number of pixels in the upper
half of the intensity range for either SMEMB, SM1 or SM2. Adeoye et al (1) described
details of this method.

Data Analysis and Statistics
Contractile stresses generated from raw grams of strain were calculated as ratios of
force per cross-sectional area where force equals tension (g) X acceleration due to gravity
and cross-sectional area equals wall thickness (µm) X artery segment length.
Comparisons of contractile stresses were made using analysis of variance (ANOVA). All
data sets were confirmed to be normally distributed using the D’Agostino-Pearson
analysis and statistical power was at least 0.8.
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One-way ANOVA was used to test the hypothesis in each experiment. Duncan’s
Multiple Range analysis was used to make post-hoc comparisons between means within
the ANOVA.
Concentration-response curves were analyzed by computer-assisted excel sigmoid
regression fits. Statistical significance was considered a P value <0.05 and n value
represents the number of arteries / animals used in each experimental group.

Results
Effects of Long-term Hypoxia on Arterial Reactivity to Nerve Stimulation
Maximum responses to transmural electrical stimulation of the adrenergic nerve
terminals occurred at 16 Hz in both normoxic (0.009 ± 0.007) and hypoxic (0.137 ± 0.14)
cerebral artery segments (Figure 1). Hypoxic acclimatization produced a 1422% increase
in frequency-dependent constriction compared to responses in normoxic arteries. This
frequency-dependent constriction was sensitive to blockade by either 10-7 M tetrodotoxin
or 10-6 M phentolamine.
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Figure 1: Hypoxia upregulates sympathetic perivascular activity in ovine cerebral
arteries. In fetal ovine middle cerebral arteries, contractile responses to electrical
transmural stimulation of sympathetic perivascular adrenergic nerves were enhanced
following 110 days of hypoxic acclimatization. Results are presented as mean ± SEM for
n = 9 for fetal normoxic arteries and n = 6 for fetal hypoxic arteries. Significant
differences imply P < 0.05.
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Effects of Long-term Hypoxia on Expression of Dopamine-βHydroxylase
In fetal ovine cerebral arteries, western blot analysis of the enzyme, dopamineβ-hydroxylase, required for the rate limiting reaction for the synthesis of norepinephrine,

yielded (per µg standard protein) 0.25 ± 0.05 and 1.17 ± 0.23 in normoxic and hypoxic
arteries respectively (Figure 2). Hypoxic acclimatization thus produced ~ 4.5 fold
increase in DbH expression compared to normoxic arteries. Similarly, fluorescent
immunohistochemistry analysis showed greater fluorescence for DβH in hypoxic arteries
compared to normoxic arteries.
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Figure 2: Hypoxia upregulates expression of dopa-β-hydroxylase in ovine cerebral
arteries. The schematic shows the steps leading to the synthesis of Norepinephrine
(Figure 2, upper panel). Dopamine-β-hydroxylase is the rate-limiting step in the synthesis
of NE. In fetal ovine middle cerebral arteries, western blot analysis showed that hypoxic
acclimatization resulted in about 290% increase in dopa-β-hydroxylase expression
(Figure 2 - left panel). Immunohistochemical analysis also showed that hypoxic
acclimatization upregulates expression of dopa-β-hydroxylase (Figure 2 – right panel).
Sympathectomy downregulates dopa-β-hydroxylase expression in both normoxic and
hypoxic arteries (Figure 2 – right panel).
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Effects of Sympathetic Perivascular Nerves on Arterial Wall
Thickness and Stiffness
In nerve intact arteries, arterial medial wall thicknesses averaged (in µm) 36.36 ±
3.3 and 48.81 ± 3.14 in normoxic and hypoxic arteries respectively. Hypoxic
acclimatization thus produced a 34% increase in arterial wall thickness compared to
normoxic arteries (Figure 3). Medial wall thicknesses of arteries from denervated
animals averaged (in µm) 31.99 ± 2.17 and 41.56 ± 1.32 in normoxic and hypoxic
groups respectively (Figure 3). Hypoxic acclimatization thus produced a 30% increase in
medial wall thickness compared to values obtained in normoxic arteries. Whereas
denervation had no significant effect on normoxic arteries, it produced a 15% decrease in
medial wall thickness in hypoxic arteries.
Also in nerve intact arteries, stiffness coefficients averaged 30.70 ± 18.52 for
normoxic arteries and 60.53 ± 20.05 for hypoxic arteries at maximum strain. Hypoxic
acclimatization thus produced a 97% increase in stiffness (Figure 3, Right panel). In
denervated arteries, stiffness coefficients averaged 65.11 ± 21.93 for normoxic arteries
and 174.82 ± 61.68 for hypoxic arteries at maximum strain. Hypoxia acclimatization thus
produced a 168% increase in stiffness in denervated arteries. Denervation resulted in a
112% increase in stiffness in normoxic arteries and a 189% increase in hypoxic arteries.
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Figure 3: Sympathetic perivascular nerves mediate hypoxic effects on cerebral artery
structure. Hypoxic acclimatization significantly increased arterial wall thickness by 34%
and 30% in nerve intact and SANX arteries respectively. Whereas sympathectomy had no
effect on normoxic arteries, it produced a 15% decrease in medial wall thickness in
hypoxic arteries (Figure 3, left panel). Data is presented as mean ± SEM for n = 5 for all
experimental groups. Also hypoxic acclimatization produced a 97% and 168% increase in
stiffness in nerve intact and SANX arteries respectively. Sympathectomy resulted in a
112% and 189% increase in stiffness in normoxic and hypoxic arteries respectively. Data
here represents mean ± SEM for n= 5 for both normoxic groups and hypoxic SANX
group and n = 4 for hypoxic intact group. Statistical significance denoted by (*)
represents P < 0.05.
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Effect of Sympathetic Perivascular Nerves on Contractile Protein
Organization
For SMemb - SMαA, colocalization coefficients averaged 0.008 ± 0.001 and
0.0056 ± 0.0013 in nerve intact normoxic and hypoxic arteries respectively. Hypoxic
acclimatization thus resulted in a 30% decrease in SMemb - SMαA colocalization
compared to normoxic arteries. In denervated arteries, colocalization coefficients
averaged 0.012 ± 0.002 and 0.0116 ± 0.0019 in normoxic and hypoxic arteries
respectively. Hypoxic acclimatization thus had no effect on SMemb - SMαA in
denervated arteries. Denervation produced a 50% and 107% increase in SMemb - SMαA
colocalization in normoxic and hypoxic arteries respectively (Figure 4).
For SM1- SMαA, colocalization coefficients averaged 0.023 ± 0.003 and 0.005 ±
0.002 in nerve intact normoxic and hypoxic arteries respectively. Hypoxic
acclimatization thus resulted in a 78% decrease in SM1- SMαA colocalization compared
to normoxic arteries. In denervated arteries, colocalization coefficients averaged 0.015 ±
0.002 and 0.013 ± 0.003 in normoxic and hypoxic arteries respectively. Hypoxic
acclimatization thus had no effect on SM1- SMαA colocalization in denervated arteries.
Whereas denervation produced a 35% decrease in SM1- SMαA, colocalization in
normoxic arteries, it produced a 160% increase in SM1- SMαA, colocalization in
hypoxic arteries (Figure 5).
For SM2 - SMαA, colocalization coefficients averaged 0.0069 ± 0.0016 and 0.0155
± 0.00250 in nerve intact normoxic and hypoxic arteries. Hypoxic acclimatization thus
resulted in a 125% increase in SM2 - SMαA colocalization in nerve intact arteries. In
denervated arteries, colocalization coefficients averaged 0.0030 ± 0.00029 and 0.003 ±
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0.00068 in normoxic and hypoxic arteries respectively. Hypoxic acclimatization hence
had no effect on SM2 - SMαA colocalization in denervated arteries. Denervation
significantly decreased SM2 - SMαA colocalization in both normoxic (57%) and hypoxic
arteries (81%) (Figure 6).
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Figure 4: Sympathetic perivascular nerves alter interactions between SMemb and
SMαA. Hypoxic acclimatization resulted in a 30% decrease in SMemb - SMαA
colocalization in nerve intact arteries but had no effect in SANX arteries. In contrast,
sympathectomy resulted in 50% and 107% increase in colocalization between the two
proteins in normoxic and hypoxic arteries respectively. Data here represent mean ± SEM
for n = 5 for experimental groups. Statistical significance denoted by (*) represents P <
0.05
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Figure 5: Sympathetic perivascular nerves alter interactions between SM1 and SMαA.
Hypoxic acclimatization resulted in a 78% decrease in SM1 - SMαA colocalization in
nerve intact arteries but had no effect on colocalization between the two contractile
proteins in SANX arteries. Similarly, sympathectomy resulted in 35% decrease in SM1 SMαA colocalization in normoxic arteries but produced a 160% increase in SM1 - SMαA
colocalization in hypoxic arteries. Data here represent mean ± SEM for n = 5 for all
experimental groups except FN SANX in which n = 6. Statistical significance denoted by
(*) represents P < 0.05
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Figure 6: Sympathetic perivascular nerves alter interactions between SM2 and SMαA.
Hypoxic acclimatization resulted in a 125% increase in SM2 - SMαA colocalization in
nerve intact arteries but had no effect on colocalization between the two contractile
proteins in SANX arteries. In sharp contrast, sympathectomy resulted in 57% and 81%
decrease in SM2 - SMαA colocalization in normoxic and hypoxic arteries respectively.
Data here represent mean ± SEM for n = 5 for all experimental groups. Statistical
significance denoted by (*) represents p < 0.05.
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Sympathetic Perivascular Nerves Mediate Hypoxic Remodeling
Through NE and its α-1 Adrenoceptors
In hypoxic denervated arteries, SM2 - SMαA colocalization coefficients averaged
0.002 ± 0.001, 0.002 ± 0.0004, 0.005 ± 0.001 and 0.002 ± 0.001 in fresh, starved, NE
treated and NE+prazosin tissues respectively. Starved segments were incubated in
Dulbecco’s modified medium (DMEM) with basic essential and non-essential amino
acids for 48 hr; NE and NE+Prazosin treated segments were starved for 24 hrs and then
treated with the respective drugs for 24hrs. 48 hr starvation had no statistically significant
effect on SM2 - SMαA colocalization, whereas NE increased SM2 - SMαA
colocalization by 150% and addition of prazosin reversed this increase by 60% (Figure
7).
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Figure 7: NE acts through its a-1 adrenoceptors in mediating trophic effects of
sympathetic perivascular nerves on middle cerebral arteries. In hypoxic denervated
arteries, 48 hr starvation treatment i.e. incubation in media with basic essential and nonessential amino acids, produced no significant effect on SM2 - SMαA colocalization. NE
treatment produced a 150% increase in SM2 - SMαA colocalization and addition of
prazosin to NE treated arteries decreased SM2 - SMαA by 60%. Data here represent
mean ± SEM for n = 6 for all experimental groups except fresh arteries in which n = 4.
Statistical significance denoted by (*) represents P < 0.05
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Discussion
This study offers 5 novel findings in endothelium denuded ovine cerebral arteries.
First, reactivity to electrical nerve stimulation was significantly increased in fetal hypoxic
compared to normoxic control arteries. Second, dopa beta hydroxylase (DβH), the rate
limiting enzyme in the synthesis of NE is significantly upregulated in fetal hypoxic
compared to normoxic control arteries; and denervation ablates DBH. Third, medial wall
thicknesses were signicantly increased in nerve intact fetal hypoxic arteries compared to
normoxic arteries and denervation produced opposite effects. In like manner, hypoxia
also significantly increased arterial stiffness and this effect was modulated by
sympathectomy in both normoxic and hypoxic arteries. Fourth, hypoxia significantly
decreased colocalization of non-contractile (SMemb) and intermediate (SM1) myosin
isoforms with SMαA, but increased colocalization of myosin contractile isoform (SM2)
with SMαA. In contrast, sympathectomy significantly increased colocalization of
SMemb with SMαA, but decreased colocalization of SM1 and SM2 with SMαA. Fifth,
perivascular nerve induced NE mediates hypoxic vascular remodeling of ovine cerebral
arteries through α-1 adrenoceptors.

Long-term Hypoxia Enhances Arterial Reactivity to Electrical
Stimulation
Hypoxia has been shown to induce structural changes (34) in blood vessels that
consequently alter their function (34, 43). In response to low oxygen levels, hypoxia
inducible factor (HIF1-α) binds to hypoxia response elements present on promoter
regions of angiogenic and glycolytic genes (24). VEGF is widely known as the most
prominent of the angiogenic genes and has been overwhelmingly shown to mediate
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processes of angiogenesis and vasculogenesis in response to hypoxia (19). Of recent, in
addition to mediating angiogenesis, VEGF has been implicated in vascular remodeling
which is a dynamic process involving structural changes secondary to different
endogenous and exogenous stimuli (13). VEGF signals through its receptor-2/ fetal liver
kinase-1 (Flk-1) to enhance angiogenesis, mitogenesis and cell survival and through its
receptor-1/fms-like tyrosine kinase 1 (Flt-1) to enhance ligand binding during
angiogenesis (1, 15). Though many studies have suggested VEGF to be a highly specific
mitogen for endothelial cells (14), more recent findings have shown its effects on nonendothelial cells such as smooth muscle cells (18), tumor cells (8), chondrocytes (7) and
neurons (35, 38). In testing the hypothesis that hypoxic remodeling of arteries occurs
indirectly through the perivascular sympathetic nerves, we conducted electrical nerve
stimulation of ovine fetal middle cerebral arteries. Results here showed a significant
increase in response to transmural nerve stimulation in hypoxic arteries compared to their
normoxic controls. Consistent with previous studies conducted in non-ovine species, a
possible mechanistic explanation for this observation could be an upregulated
sympathetic innervation of the arterial system during periods of hypoxia {Ruijtenbeek,
2000, 11104750}. Damon in her 2005 publication also suggested that sympathetic
innervation modulates arterial medial cell differentiation (10). Sympathetic
hyperinnervation and enhanced smooth muscle cell differentiation might ultimately result
in an increase in cell populations of a potent contractile phenotype during periods of
hypoxia. To test the hypothesis that upregulated perivascular nerve activity in hypoxic
arteries mediates enhanced reactivity to nerve stimulation, we quantified DβH, the rate
limiting enzyme in NE synthesis.
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NE From Sympathetic Perivascular Nerves Mediates Response to
Transmural Stimulation in Hypoxic Arteries
To determine the possible involvement of NE, the main sympathetic postganglionic
neurohormone in the upregulated reactivity of hypoxic arteries to transmural stimulation,
we quantified DbH, the rate-limiting enzyme in the synthesis of NE. To minimize
influence of the endothelium involving nitric oxide (NO) co-release of NE (4) and also to
test the indirect remodeling effect of VEGF via sympathetic perivascular nerves, we
made use of endothelium-denuded arteries from both normoxic and hypoxic arteries.
Western blot quantification of DβH showed a 354% increase in hypoxic arteries
compared to their normoxic controls, suggesting that sympathetic perivascular nerve
activity was significantly upregulated during hypoxic acclimatization. Similarly,
immunohistochemical analysis revealed a greater DβH fluorescence in hypoxic compared
to normoxic arteries and denervation ablates this response. This result is consistent with
non-ovine studies that suggest a hypoxia induced increase in sympathetic inputs from
perivascular nerves (16){Ruijtenbeek, 2000, 11104750}(26). Other possible mechanisms
may involve a hypoxia-induced attenuation of presynaptic inhibition of current-induced
release of NE (5, 28) or an enhancement of maturation of fetal arteries through shortening
of the synaptic cleft width (28) both of which remain to be morphometrically tested.
Together these findings suggest that hypoxic acclimatization results in potent
upregulation of sympathetic perivascular innervation and/or activity.

Sympathetic Perivascular Nerves Mediate Hypoxic Changes in
Arterial Structure
Long-term acclimatization to hypoxia has been shown to result in adaptive changes
in arterial structure that consequently alter function (34, 43). To test the hypothesis that
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hypoxic upregulation of sympathetic innervations alters arterial structure we measured
arterial thicknesses and stiffness coefficients in arteries harvested from intact and
denervated normoxic and hypoxic sheep. Consistent with literature, our results showed
that hypoxia significantly increased medial wall thickness (42, 50) and denervation
produced the opposite effect in hypoxic arteries with no effect in normoxic arteries.
These results suggest that hypoxia might be inducing cell hyperplasia (3) or hypertrophy
(32, 33, 36) in the wall intima and that perivascular nerves support this process possibly
through enhanced cellular differentiation and proliferation (10). Similarly, consistent with
literature, hypoxia significantly increased stiffness of the cerebral arteries (11, 45),
however denervation increased stiffness further and more so in hypoxic arteries.
Increases in stiffness observed in hypoxic arteries could be possibly due to hypoxia
induced increases in cellular collagen content or increased ratio of collagen to elastin
fibers in smooth muscle cells (11, 45). Sympathectomy enhanced hypoxia induced
arterial stiffness suggesting that perivascular nerves attenuate arterial stiffness through
mechanisms that might involve release certain vasotrophic substances such as NO (9) that
enhance vasodilatation and consequently reduce arterial stiffness (17, 22).

Sympathetic Perivascular Nerves Mediate Hypoxia-induced Changes
in Arterial Function Through Alteration of Contractile Protein
Colocalization
Coupling between smooth muscle thick filaments (Myosin chains) and thin
filaments (SMαA) in the presence of ATP initiates contractile force, which is propagated
to the cell membrane by cytoskeletal proteins (20, 48). Recent works from our lab have
shown potent changes in contractile protein abundances and interactions (6) secondary to
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hypoxic acclimatization (1, 21). To test the hypothesis that sympathetic perivascular
nerves mediate hypoxic changes in smooth muscle cell interactions between the three
myosin heavy chain isoforms (SMEMB, SM1 and SM2) and SMαA, we conducted
immunohistochemistry and confocal colocalization imaging. Results showed that
SMemb, a smooth muscle myosin heavy chain isoform with characteristic synthetic
phenotype, colocalization with SMαA was shown to be significantly downregulated by
hypoxia, and denervation produced the opposite effect. This result suggests a.) That longterm hypoxia promotes cellular reorganization which downregulates colocalization of
non-contractile and synthetic myosin with SMαA b.) That sympathetic perivascular
nerves mediate hypoxic dedifferentiation of certain subsets of the smooth muscle cells
with consequent decreases in SMemb - SMαA colocalization. Similarly, SM1 (smooth
muscle myosin heavy chain intermediate contractile isoform) colocalization with SMαA
decreased with hypoxia suggesting that hypoxia promotes factors that inhibit coupling
between both non-contractile and intermediate contractile isoforms of myosin with
SMαA. Whereas denervation decreased SM1- SMαA colocalization in normoxic arteries,
denervation increased their colocalization coefficient in hypoxic arteries, suggesting that
sympathetic perivascular nerves preferentially support a downregulation of colocalization
between synthetic myosin phenotypes and SMαA in hypoxic arteries. In sharp contrast to
SMemb and SM1, long-term hypoxia significantly increased SM2 (fully contractile
myosin isoform) colocalization with SMαA and denervation potently produced opposite
effects. This result shows that whereas hypoxia downregulated colocalization of SMemb
and SM1 with SMαA, it potently enhanced SM2- SMαA colocalization, which supports
contractile force, and perivascular sympathetic nerves seem to mediate this process. The
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exact mechanisms by which sympathetic perivascular nerves alter the phenotype of
smooth muscle cells and their marker proteins remain exciting topics of future. Some
studies in non-ovine species have suggested that sensory nerves have the ability to limit
vasoconstriction of arteries during periods of perivascular nerve stimulation (49). It is
possible that this protective effect is compromised during periods of hypoxia.

NE Mediates Hypoxic Reorganization of Contractile Proteins via its α1 Adrenoceptors
Sympathetic nerves have been overwhelming shown to exert a protective effect on
vital organs during periods of stress through the release of catecholamines (5); of which
norepinephrine is the most common. Also perivascular nerve stimulation has been shown
to result in the release of norepinephrine from the nerve terminals in the end organs (12).
NE signals predominantly through α-1 adrenoceptors present on blood vessels (46).
Using SM2- SMαA colocalization as a reporter assay, we tested the hypothesis that NE
mediates hypoxic changes in contractile protein interactions via its α-1 adrenoceptors. In
arteries harvested from sympathectomized hypoxic fetal sheep, 48 hrs of starvation in
organ culture produced no change; NE produced a significant increase in SM2- SMαA
colocalization and addition of prazosin (an α-1 adrenoceptor blocker) produced a marked
decrease in SM2- SMαA colocalization. This result suggests that remodeling effects of
hypoxia characterized by a preferential increase in colocalization between myosin
contractile isoform, SM2 and SMαA occur through NE signaling via its α-1
adrenoceptors present on ovine cerebral arteries.
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Overview
VEGF has been suggested to mediate hypoxic vascular remodeling in addition to its
well-established role in angiogenesis and vasculogenesis through its receptor tyrosine
kinases. Here we have explored the possibility of VEGF contributing to hypoxic vascular
remodeling of fetal ovine cerebral arteries through VEGF receptors present on
sympathetic perivascular nerves. First set of experiments showed that response to
electrical transmural stimulation was significantly increased in hypoxic fetal (FH) arteries
compared with their normoxic controls (FN) (Figure 1). This was partially explained by
a 3-fold increase in dopa-β-hydroxylase in FH group compared to FN, which is the ratelimiting enzyme for NE synthesis (Figure 2). In both groups denervation ablated DBH
increases (Figure 2). Consistent with existing literature, long term hypoxia produced
significant increases in medial arterial wall thickness and stiffness (Figure 3). Whereas
denervation decreased wall thickness, it further modulated stiffening of the arteries,
suggesting that sympathetic perivascular nerves support hypoxic increases in arterial wall
thickness but attenuate stiffening of arteries possibly through nerve induced increases in
NO. Long-term hypoxia resulted in significant decreases in SMemb – SMαA
colocalization (Figure 4) as well as SM1 – SMαA colocalization (Figure 5) but
increased SM2 – SMαA colocalization (Figure 6). Denervation produced opposite
effects on colocalization of these pairs of contractile proteins suggesting that sympathetic
perivascular nerves mediate hypoxic shifts in phenotype from a synthetic to a more
contractile one resulting in increased reactivity to transmural current stimuli. Organ
culture denervated hypoxic arterial segments with NE produced significant increases in
SM2 – SMαA colocalization (Figure 7) and co-cultures with prazosin ablated these
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increases. Together these results support our hypothesis that perivascular nerves mediate
hypoxic vascular remodeling through phenotypic shifts in smooth muscle cell phenotype.
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CHAPTER FIVE
CONCLUSIONS & FUTURE DIRECTIONS
A broad spectrum of maternal conditions ranging from smoking, diabetes, chronic
hypertension or pregnancy induced hypertensive disorders create a hypoxic environment
to the developing fetus. Hypoxia remains one of the most common etiologic and/or
contributory factors to increased fetal morbidity and mortality both in the USA and the
world at large. Whereas severe acute episodes are lethal, moderate to mild chronic
episodes though compatible with life result in altered cardiovascular functioning.
Grounded knowledge on mechanisms of these altered cardiovascular patterns becomes
extremely important to developing therapeutics to ensure survival of the developing fetus
as well as treating future complications.
HIF-1 has been regarded as the global mediator of hypoxia since its discovery
almost three decades ago. The activity, stability and post translational modifications of its
oxygen sensing and regulated subunit (α subunit) determines regulate the induction of
transcription of other hypoxia responsive genes including : glycolytic enzyme genes,
erythropoietin and VEGF amongst others. VEGF is largely known as the mediator of
processes of angiogenesis and vasculogenesis in normal embryonic development,
collagen constriction and neovascularization during wound healing and tumorigenesis
involving expansion of vascular network supplying the cancer cells. VEGF
overwhelmingly contributes to processes of proliferation and cell survival which is
desirable during physiologic developmental processes but adverse in pathologic
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conditions such as tumorigenesis. Although VEGF is famously known for its role in
angiogenesis and vasculogenesis, recent studies have implicated this transcription factor
in vascular remodeling, which is a dynamic process involving changes in vessel structure
resulting in altered function. Because of the important role of VEGF in angiogenesis and
vascular remodeling in physiologic and pathologic processes, it becomes important and
of high clinical relevance to elucidate mechanisms through which this vasotrophic factor
signals.
The first chapter of this dissertation introduces HIF-1a, its induction of
transcription of VEGF gene and translational synthesis of the cytokine. The overall
hypothesis “ VEGF mediates hypoxic vascular remodeling through a direct effect on the
vascular smooth muscle and indirectly through the sympathetic perivascular nerves” for
this thesis was introduced. Whereas VEGF is generally known as a specific mitogen for
endothelial cells, recent findings have suggested its direct effect on non-endothelial cells
such as chondrocytes, neural cells and smooth muscle cells resident in the intimal layer of
arteries. Current knowledge on VEGF and its principal tyrosine receptor kinases flt1(VEGF receptor 1) and flk-1 / kdr (VEGF receptor 2) were highlighted in this chapter.
Chapter 2 tested and provided data that supports the hypothesis that smooth
muscle cells are organizaed into lamina of similar phenotype with characteristics that
depend on the relative position between the lumen and the adventitia and involve the
direct effects of vasotrophic factors such as VEGF, which could potently act
independently of the vascular endothelium in an age-dependent manner.
Chapter 3 highlights our novel study which tested and provided data to support
the hypothesis that hypoxic increases in VEGF not only promotes angiogenesis but
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contributes to remodeling of artery wall structure and contractility through phenotypic
transformation of smooth muscle. In this study low dose VEGF (3 ng/ml) replicated
hyoxic decreases in colocalization of SMemb with SMαA in fetal arteries and decreases
in colocalization of SM2 with SMαA in adult arteries.
With most of the current literature known on arterial remodeling focused on
pathologies in adult vasculature, it becomes important to conduct research on
mechanisms involved with hypoxic vascular remodeling in fetal vasculature. Chapter 4 of
this dissertation tested and provided data to support the hypothesis that VEGF contributes
to hypoxic fetal vascular remodeling through changes in the abundance, organization and
function of contractile proteins, with emphasis on SMαA, MLCK and MLC20. VEGF in
organ culture replicated hypoxic increases in SMαA and MLC20 abundances as well as
precipitous decreases in MLCK. Similarly, VEGF in organ culture mimiked hypoxic
increases in colocalization of MLCK with SMαA, MLC20 with SMαA and MLCK with
MLC20 despite marked decreases in MLCK abundance, thus suggesting that hypoxia and
VEGF exert distinct effects on each contractile protein and that contractile protein
abundance and organization are differentially regulated. Of remarkable importance in this
study is the short term increase in VEGF and long term increases in VEGF receptor
tyrosine kinases (flt-1 and flk-1), suggesting that hypoxic vascular remodeling initiated
by VEGF are maintained long-term by potent increases in VEGF receptors.
Having tested mechanisms involved with hypoxic vascular remodeling in fetal
ovine carotid arteries, we conducted a parrallel study to test the hypothesis that chronic
hypoxia produces a sustained increase in the density of vascular VEGF receptors, which
in turn helps mediate the long-term effects of hypoxia on vascular remodeling in adult
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ovine carotid arteries. Chapter five shows that whereas VEGF levels were similar to basal
levels VEGF receptors 1 and 2 (flt-1 and flk-1) were significantly increased after 110
days of hypoxic acclimatization in ovine adult carotid arteries, suggesting that the
mechanism through which remodeling effects of hypoxia are maintained long term is
through upregulation of VEGF receptor densities. Also this study showed that VEGF in
culture replicated hypoxic increases in SMαA and MLC20 but produced no significant
effect on MLCK suggesting that post-natal maturation alters reactivity to MLCK. Also,
VEGF in culture replicated hypoxic effect only on MLC20 colocalization with SMαA,
further supporting the hypothesis that reactivity of arteries to hypoxia and VEGF are
fundamentally different in fetal and adult ovine species.
Chapter 6 explored the hypothesis that hypoxic increases in VEGF contributes to
arterial remodeling possibly through activation of VEGF receptors on sympathetic
perivascular nerve leading to altered trophic input to the arterial wall. This chapter shows
that increased response to transmural electrical stimulation in hypoxic arteries compared
to normoxic controls might be related to upregulation of sympathetic inputs to the artery.
Also long term hypoxia was shown to modulate contractile differenctiation as evidenced
by decreased colocalization of non-muscle myosin heavy chain (SMemb) with SMαA as
well as simultaneous increase in colocalization between fully contractile smooth muscle
heavy myosin chain (SM2) with SMαA. Sympathectomy ablated the effects of hypoxia
on phenotypic shifts of the contractile proteins. Also NE in organ culture potently
increased colocalization between SM2 and SMαA and prazosin (α-1 adrenoceptor
blocker) attenuated this increase.
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Future relevant work geared towards advancement of the VEGF remodeling
hypothesis would involve testing involvement of other vasotrophic factors in hypoxic
remodeling since there is overwhelming evidence that VEGF does not work in isolation.
Platelet derived growth factor (PDGF) and fibroblast growth factor (FGF) in particular
have been closely associated with the role VEGF plays in hypoxic remodeling. With
VEGF able to bind with PDGF receptors, this vasotrophic factor occupies the front line in
future studies on involvement of other cytokines in hypoxic vascular remodeling. This
dissertation focused on the role of VEGF and its receptors in long-term hypoxic vascular
remodeling. One of the novel findings was upregulation of VEGF receptors during longterm hypoxic acclimatization; clearly it will be logical to assess levels of VEGF receptors
during acute phases of hypoxia. Relevant experiments here will involve sheep made
acutely hypoxic via blowing of nitrogen (N2) through a tracheostomy for a week and then
assessing VEGF receptor density via western blotting on the carotid arteries and middle
cerebral arteries. Since our work primarily focused on role of growth factors and their
receptors on hypoxic vascular remodleing with emphasis on VEGF, the next logical line
of study will be to assess intracellular kinases that couple these agonist-receptor signaling
to the nucleus of the cell. Assessment of potential intracellular kinases that have been
suggested in VEGF signaling would involve – quantification of ERK 1 and 2 and P-I-3
Kinase and their targets (Akt, phospho-Akt and phospho-ERK), use of their antagonists
in culture and then assessing their effect on contractile protein expression, organization
and contractility of the arteries. ERK 1 and 2 antagonists that have been suggested in the
literature include U0126 and PD98059 while those of PI3 kinase are Wortmannin and
LY294002. These studies will assess potential changes of these intracellular kinases with
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hypoxia , VEGF or with ganglionectomy. The concept of short-term hypoxic increases in
VEGF but long-term return to baseline creates a research question of testing what
mechanisms mediate this process. Studies involving assessment of possible VEGF
mRNA post-transcriptional regulation via micro RNAs, alternative splicing or
riboswitches or VEGF post translational regulation via methylation, acetylation or
ubiquitination become exciting topics for future research.
Other than HIF and VEGF that have known hypoxia response elements on their
genes, studies have only hinted at a possibility of presence of HREs on contractile protein
genes and other molecules that respond to hypoxia. In our studies, MLCK has been
overwhelimingly shown to be very sensitive hypoxia necessitating the importance of
future studies to elucidating potential presence of HREs on the contractile protein genes.
In this study, we have hypothesized and tested the involvement of sympathetic
perivascular nerves with hypoxic vascular remodeling via release of NE; many studies
have however suggested that NPY is co-released with NE. Future studies would be
necessary to test the involvement of peptidergic vasotrophic factors such as NPY as well
as ATP with hypoxic vascular remodeling. Quantification of these agonists and their
receptors in nerve intact and denervated sheep as well as organ culture with them will
provide novel information about their posssible involvement with hypoxic vascular
remodeling.
VEGF is known to mediate both physiologic and pathological processes involving
angiogenesis and vasculogenesis. Tumorigenesis is one of the pathologic processes that
VEGF mediates. Over the years researchers have discovered small molecule inhibitors of
VEGF necesitating testing via clinical trials at various levels. Our organ culture model
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would serve a clinical purpose of testing the efficacy and safety of many of these small
molecule inhibitors that could serve future uses in combating the scorge of cancer
malignancy and recurrence.
Overall, from a clinical perspective, many fetal as well as maternal conditions
result in varying levels of hypoxia that adversely affect the developing fetus. These
conditions result in long hospital stay in the NICU, increased morbidity and mortality as
well as chronic altered funcitioning of various organs in the fetal body. Gaining a better
understanding of processes involved with altered functioning of the vasculature is a
valuable first step in improving and optimizing strategies geared towards better clinical
outcomes. Manipulation of vasotrophic factors such as VEGF, clearly involved with
remodeling, may provide valuable opportunities for therapy in neonates that have
survived hypoxia in-utero. The purpose of this thesis was to elucidate mechanisms
through which VEGF mediates hypoxic remodeling and by inference first steps towards
reduction of hypoxia related morbidities and mortalities.
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